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ABSTRACT 
Neisseria meningitidis is a leading bacterial cause of sepsis and meningitis globally. Beginning 
with an epidemic among Hajj pilgrims in 2000, capsular group W (W) sequence type (ST) 11 
emerged as a leading cause of epidemic meningitis in the African ‘meningitis belt’ and endemic 
cases in South America, Europe, Middle East and China.  Previous genotyping studies were 
unable to reliably discriminate less virulent W ST-11 strains in circulation since 1970 from the 
Hajj epidemic strain (Hajj clone). It is also unclear what proportion of more recent W ST-11 
disease clusters were caused by direct descendants of the Hajj clone. This work analyzes whole 
genome sequences of a global collection of over 250 meningococcal strains isolated from 
patients with invasive meningococcal disease globally from 1970 to 2014 using phylogenetic 
analyses, detailed examination of the capsule gene cluster (cps) and genes encoding major 
surface antigens.  
We found that W ST-11 strains were descendants of an ancestral strain that had undergone 
unique capsular switching events. We identified two distinct, conserved, recombination events 
within W ST-11 cps genes with W ST-22 and Y ST-23 as most likely donor lineages. In 
addition, the Hajj clone and its descendants were distinct from other W ST-11 strains in that they 
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shared a common antigen gene profile and had undergone further recombination involving 
virulence genes encoding factor H binding protein (fHbp), nitric oxide reductase (nor), and 
nitrite reductase (aniA).  Emergence of the Hajj clone may be related to recent acquisition of a 
distinct antigen-encoding gene profile and variations in meningococcal virulence genes.  
This study resolves questions about the Hajj epidemic strain that were unanswered for 15 years. 
Furthermore, the findings of this study help illuminate genomic factors associated with 
emergence and evolution of virulent meningococcal strains.   
Public Health significance: This dissertation provides genomic markers that reliably distinguish 
epidemic from sporadic W ST-11 strains that are applicable to molecular surveillance of N. 
meningitidis. Data presented in this work also demonstrate the need for a group W vaccine 
disease in the meningitis belt that can be potentially used beyond the meningitis belt in South 
Africa, parts of Latin America, and Europe that are facing the emergence of W ST-11. 
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1.0 INTRODUCTION 
1.1 BACKGROUND 
Neisseria meningitidis (meningococcus, Nm) is a leading cause of meningitis and sepsis1 that is 
estimated to cause over 500,000 disease cases and 50,000 deaths worldwide. There is wide 
variation in incidence and rates and strain distribution between global regions and over time.  
N. meningitidis, a gram negative intracellular bacterium, is an exclusive human pathogen that is 
part of the normal pharyngeal flora of about 10% of the adult population. Occasionally, 
pathogenic meningococcal strains cross the mucosal barrier of the nasopharynx to cause invasive 
meningococcal disease (IMD). IMD most commonly manifests as bacteremia and/or meningitis.2 
Less common manifestations of IMD include pneumonia, septic arthritis or pericardial 
infection.3 IMD is often a fatal disease; mortality rates range between 5-10% with survivors 
suffering from long term sequelae such as hearing loss and other neurologic deficits, limb 
amputation, and renal damage.4 Transmission is through close contact with airway droplets of 
asymptomatically colonized individuals. Risk factors for invasive meningococcal disease are 
close contact with an IMD patient, cigarette smoking, kissing, immune complement deficiency 
and crowding in bars, dormitories or large human gatherings.5 
Jafri et al6 classified global meningococcal disease incidence pattern into countries with 
epidemic and/or high endemic disease with incidence rates >10 cases per 100,000 population that 
comprise most African countries, Uruguay, New Zealand and Mongolia. The highest incidence 
rates of 100-1000 per 100,000 are witnessed during occasional epidemics across 21 countries7 in 
Africa collectively referred to as the ‘meningitis belt’ (Figure 1).8 Moderate endemic rates are 
between 2-10 cases per 100,000 population and occur in South Africa, some European countries, 
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Brazil, Cuba and Australia. Remaining countries have low endemic rates (<2/100,000). IMD in 
some countries shows a bimodal incidence pattern with a large peak in infants and children less 
than five years old and a smaller peak among adolescents and young adults. 
 
 
 
Figure 1: Meningitis belt, 2006  
(Source: U.S. Centers for Disease Control and Prevention) 
1.1.1 Molecular Characterization of N. meningitidis 
Meningococci are classified into capsular groups (serogroups) based on serologic and genetic 
characteristics of their polysaccharide capsule, a major virulence determinant and the target of 
capsular group-specific vaccines. Of thirteen known capsular groups, six major groups A, B, C, 
W, X and Y account for almost all cases of invasive meningococcal disease.9,10 The 
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epidemiologic pattern of meningococcal disease differs by capsular type over time. Group A is 
most common cause of  epidemic meningitis; for example, an outbreak of group A 
meningococcal disease in 1996 in the meningitis belt resulted in over 250,000 cases and 25,000 
deaths.11 Capsular group B causes sporadic disease and small outbreaks in low to moderate 
endemic countries12,13 but is very uncommon in the meningitis belt. Group C also causes 
sporadic disease and small case clusters globally,14 although group C strains occasionally cause 
large epidemics in the meningitis belt.15 In recent decades, groups W and Y have emerged to 
cause significantly higher number of meningococcal disease cases globally16-22 while smaller 
group X23,24 epidemics have occurred in the meningitis belt. 
Multilocus sequence typing (MLST), which is based on sequencing DNA fragments of 7 
housekeeping genes, is the method of choice for determining the genetic lineage of N. 
meningitidis.25 Strains of the same sequence type (ST) share a common lineage and closely 
related STs are grouped under the same clonal complex (cc). A relatively small number of MLST 
lineages, termed either ‘hypervirulent’ or ‘hyperinvasive’ lineages cause a disproportionately 
greater percentage of IMD cases. There is a loose correlation between MLST lineage and 
capsular group that changes over time.  
Major outer membrane proteins PorA and PorB are important virulence determinants and the 
basis of serologic classification of meningococci.9 PorA genotype, which is based on peptide 
sequence variation within two variable regions, VR1 and VR2, combined with MLST is a very 
powerful tool for surveillance. PorB and fetA  genotyping schemes are often used to further 
characterize invasive meningococcal strains.5 Factor H binding protein (FHbp), along with other 
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surface proteins Nhba and NadA, is an antigen used in polysaccharide capsule-independent 
vaccines that have been developed for prevention of group B infection.26 
In recent years whole genome sequencing (WGS) of meningococcal strains is expanding the 
scope of meningococcal strain typing by providing unprecedented level of detail on genetic 
diversity of meningococci. WGS studies have shed light on the genetic mechanisms underlying 
meningococcal strain emergence27,28, virulence29 and vaccine design.30 WGS studies are 
facilitated by sites that make data publically available and provide comparative tools such as 
PubMLST (pubmlst.org/neisseria/).31,32 PubMLST is especially well suited for comparison of 
newly sequenced meningococcal isolates to wide selection of historical strains.   
1.1.2 Meningococcal Virulence  
Meningococcal outer membrane contains several components that are important for virulence of 
which polysaccharide capsule is the most important. Of 13 known capsular groups, six (A, B, C, 
Y, W, X) account for nearly all cases of IMD. Also, meningococci lacking a capsule, though 
common among asymptomatic carriage strains, almost never cause invasive disease. The capsule 
is involved in resisting phagocytosis, opsonization and complement dependent lysis during 
human infection.3 On the outer membrane, type IV pili are involved in meningococcal adhesion 
and together with opacity proteins Opa and Opc mediate translocation through human 
endothelium. Other adhesins such as Nhha, NadA, Nadr and App also mediate meningococcal 
attachment and translocation. Factor H binding protein, FHbp prevents human complement 
activation by binding to human factor H.26  Other virulence factors are outer membrane proteins 
PorA, PorB, FetA, iron uptake proteins  and endotoxin.9  
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N. meningitidis frequently undergoes genetic change through spontaneous mutation and 
horizontal transfer of genetic material from meningococcal or other bacterial species. 
Homologous recombination drives widespread virulence gene exchange among Neisseria 
species29 causing substantial genetic variability even among meningococcal isolates of the same 
clonal complex.33 Recombination involving major outer membrane antigen genes, also known as 
“antigenic shift”, has been linked to increased incidence of meningococcal disease.20  Capsular 
switching, which involves acquisition of novel capsule specific genes through recombination, 
also facilitates the emergence and persistence of virulent meningococcal lineages.34-36 Through 
capsular switching, defined as presence of different capsular phenotypes within the same clonal 
complex, meningococcal strains belonging to virulent lineages may escape vaccine induced 
immunity. Surveillance studies have demonstrated that capsular switching is common among 
IMD isolates.35,36 
1.1.3 Epidemiology of capsular group W N. meningitidis 
N. meningitidis capsular group W (W) was first observed among military recruits in the United 
States in the late 1960s.37 W was associated with sporadic IMD cases globally in the 1970s 
through the mid-1990s. Active surveillance in the United States identified W in 2-4% of invasive 
meningococcal isolates from 1992-1998.38 Likewise in Canada, W caused 3-6% of annual 
reported IMD cases in 1997-1999.39 In the meningitis belt, W was identified in 3.1% of 349 
endemic meningococcal disease strains from Senegal and Niger in 1981-1982 and 7.3% of 41 
strains from the Gambia.40 In 1992-1995, an unexpectedly high proportion of W ST-11 (43%) 
was observed in 14 endemic case isolates in Gambia and Mali.41 In Brazil, W represented <2% 
of all meningococcal disease isolates from 1990-2001.42 
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W emerged as an important cause of IMD following  a large outbreak among Hajj pilgrims in 
Mecca, Saudi Arabia in 2000 which resulted in over 400 cases and 52 deaths were recorded 
among pilgrims and their close contacts across 16 different countries in Europe, Africa, Middle 
East, Southeast Asia and the United States.16,43 In 2002, a quadrivalent polysaccharide vaccine 
that covers W capsular antigen was made a visa requirement for all pilgrims traveling to Saudi 
Arabia, where no subsequent W outbreaks have been reported since then.44  
The Hajj outbreak strain was characterized as ST-11, PorA antigen gene type P1.5,2, with a 
distinct pulsed field gel electrophoresis (PFGE) pattern and 16S ribosomal RNA (16S) type 31.45 
Since 2000, several W epidemics have occurred in the meningitis belt and endemic clusters have 
been reported in South America, Europe, United States and China.17,46-49 W ST-11 was equally 
as prevalent as group A IMD strains in Burkina Faso and Niger in 2001.50 In 2002, the largest 
known W meningococcal outbreak was reported in Burkina Faso and caused an estimated 12,000 
cases and more than 1400 deaths.37  With the recent introduction of group A meningococcal 
conjugate vaccine into the meningitis belt, W ST-11 became the leading cause of IMD in that 
region.7,17,51 
Outside the meningitis belt, South Africa witnessed a doubling of meningococcal disease 
incidence during 2000 to 2005.52 High number of endemic W ST-11 cases were reported in Latin 
America,19,42,48,53,54 UK18 and Middle East.55 Smaller clusters were reported in France,56 United 
States46 and China.49 
Molecular Characteristics of the Hajj clone 
Molecular epidemiologic studies conducted at the time of the Hajj epidemic revealed that the 
Hajj clone was found to be very similar to sporadic isolates obtained from Scotland and Canada 
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in 1970, USA (1996, 1998) Europe, and the meningitis belt. The Hajj clone was 
indistinguishable from sporadic W ST-11 strains by MLST, multi-locus DNA finger-print 
(MLDF), serologic typing and porA sequencing.50,57,58 However, pre-Hajj isolates were 
distinguished by being predominantly 16S type 13 and 14.45 The high genetic and antigenic 
similarity between the Hajj clone and pre-Hajj W ST-11 strains by traditional molecular 
techniques markedly contrasts with the abrupt and dramatic changes in the epidemiology of W 
ST-11 that began with the Hajj outbreak in 2000.59 Emergence of W ST-11 epidemics and 
endemic cases beginning with the Hajj in 2000 raised a number of fundamental 
questions.37,42,45,59,60   
1) W ST-11 strains were hypothesized to have arisen result of C to W capsular switching 
event(s). W ST-11 strains are genetically and phenotypically closely related to group C ST-11 
strains which were historically the predominant capsular group within the ST-11 lineage.59 
However, the presence and extent recombination event(s) that caused C to W capsular switching 
were not established. It was also unknown whether the Hajj clone and other historical W ST-11 
strains shared the same capsular switching event(s). On one hand, high genetic similarity 
between the Hajj clone and historical W ST-11 strains supported a common ancestral 
recombination but does not explain why the Hajj clone was much more virulent compared to 
historical W ST-11 strains.  
2) A second question was whether there were genetic factors that could not be detected by 
traditional genotyping techniques either within or outside the capsule genes that could explain 
such dramatic increase in virulence.  
3) It was also hypothesized that conditions associated with the Hajj such as large numbers of 
susceptible pilgrims from all over the world, overcrowding, and polysaccharide group A/C 
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vaccines that were a visa requirement for pilgrims at the time of the outbreak contributed to the 
emergence of the Hajj clone.59  
1.2 HYPOTHESIS 
The objective of this dissertation is to study the genetic factors associated with the change in 
epidemiologic behaviour of W ST-11 meningococcal strains, with particular reference to the W 
ST-11 strain that caused the global epidemic in 2000. Based on limited genotyping data, the 
prevailing model of evolution for the W ST-11 lineage was at the time based on a number of key 
assumptions (Figure 2). First was the assumption that the W ST-11 lineage arose from an 
ancestral group C ST-11 strain, although the exact recombination event(s) and direction of 
capsular switch were not established.37,59 The second assumption was that a historical sporadic 
W ST-11 strain underwent genetic change that led to emergence of the Hajj clone.5,45,59 Third 
was the assumption that all subsequent W ST-11 epidemics and endemic clusters were caused by 
global spread of the Hajj clone.42,60,61 WGS provides excellent resolution of genetic content of 
bacterial strains that could illuminate the genetic factors responsible for the sudden emergence of 
W ST-11 in the year 2000 and beyond.   
The primary research question of this dissertation is: What are the dynamic genomic changes 
within W ST-11 from 1970-2014 that could be responsible for the abrupt change in W ST-11 
epidemiology? To address this question WGS from a large global collection of group W ST-11 
strains were studied.   
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Figure 2: Traditional model of ST-11 W evolution 
1.2.1 Specific aims 
Specific aim 1:  To assess phylogenetic relationships among the global collection of W and C 
ST-11 strains. We hypothesize that W ST-11 strains shared a close relationship representing 
clonal expansion within ST-11 lineage. We also hypothesize that more recent W ST-11 strains 
isolated following the Hajj 2000 epidemic (post Hajj strains) share even closer phylogenetic 
relationship to the Hajj clone and are phylogenetically distinct from historical W ST-11 isolates. 
Specific aim 2: To characterize capsular genes and identify recombination event(s) within both 
the Hajj and pre-Hajj capsule genes. We hypothesize that the Hajj clone had a genetic differences 
within capsule genes as compared to pre-Hajj strains. 
Specific aim 3: To determine whether the Hajj clone has a unique set of virulence genes not 
present in pre-Hajj strains. We hypothesize that the Hajj clone acquired a unique set of virulence 
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genes as compared to pre-Hajj strains and that these genes could account for increased virulence 
of the Hajj clone. 
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2.0 PAPER 1: GLOBAL EPIDEMIOLOGY OF CAPSULAR GROUP W 
MENINGOCOCCAL DISEASE, 1970-2014: EMERGENCE AND PERSISTENCE OF 
THE HYPERVIRULENT ST-11 LINEAGE (REVIEW) 
 
Mustapha M Mustapha, MBBS1 Jane W Marsh, PhD1 and Lee H Harrison, MD1* 
1Infectious Diseases Epidemiology Research Unit, University of Pittsburgh, A525 Crabtree 
Hall,130 Desoto Street, Pittsburgh, 15261PA, USA.  
*Corresponding Author: lharriso@edc.pitt.edu. 
Running title: Capsular Group W Meningococcal Disease 
Key words: Neisseria meningitidis, W135, meningitis surveillance, molecular epidemiology, 
Factor H binding protein FHbp. 
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2.1 ABSTRACT 
Following an outbreak in Mecca Saudi Arabia in 2000, meningococcal strains expressing 
capsular group W (W) emerged as an important cause of invasive meningococcal disease (IMD) 
worldwide. The Saudi Arabian outbreak strain (Hajj clone) belonged to the ST-11 clonal 
complex similar to W ST-11 causing occasional sporadic disease before 2000. Since 2000, W 
ST-11 has caused large meningococcal disease epidemics in the African meningitis belt and 
endemic disease in parts of Latin America, Europe and China. Traditional molecular 
epidemiologic methods have been unable to discriminate epidemic W ST-11 from rare sporadic 
W ST-11 strains. Genetic diversity within the gene encoding factor H binding protein fHbp, 
helps to discriminate among W ST-11 strains. Further genetic characterization of global group W 
strains is required to elucidate the role of genetic factors in the emergence of the Hajj clone and 
to monitor continued evolution of other group W lineages. 
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2.2 BACKGROUND 
Neisseria meningitidis (meningococcus), is an important cause of bacterial meningitis and sepsis 
worldwide that shows dynamic changes in strain distribution over time.5 The highest incidence 
of endemic disease and periodic epidemics occur in 13 African countries of the ‘meningitis belt.5 
The most important meningococcal virulence factor is the polysaccharide capsule, which is the 
target of capsular group specific vaccines.10 Capsular groups A, B, C, W (formerly W-135), Y 
and X cause almost all invasive meningococcal disease (IMD). Other virulence factors include 
major outer membrane proteins (OMP) PorA, PorB, FetA, FHbp and lipooligosaccharide.5 N. 
meningitidis undergoes genetic change through phase variation, homologous recombination and 
acquisition of genetic material from commensal Neisseria and/or other bacterial species.33 These 
phenomena result in substantial genetic variability even among meningococcal isolates of the 
same lineage and facilitate emergence and persistence of virulent lineages.62  
N. meningitidis capsular group W (W) was first observed among military recruits in the United 
States in the late 1960s. W emerged as an important cause of IMD following  a large outbreak 
among Hajj pilgrims in Mecca, Saudi Arabia in 2000  which resulted in over 400 cases and 52 
deaths; previously, W had not been known to cause outbreaks.16 Since 2000 several W epidemics 
have occurred in the meningitis belt and endemic clusters have been reported in South America, 
Europe, United States and China.17,46-49 Hajj outbreak strain was characterized as ST-11, PorA 
antigen gene type P1.5,2, with a distinct pulsed field gel electrophoresis (PFGE) pattern and 16S 
ribosomal RNA (16S) type 31.45  
In this review W:P1.5,2:ST-11 (capsular group:PorAVR1,VR2:sequence type) strains with direct 
epidemiologic link to Hajj 2000-2001 outbreaks are referred to as “Hajj clone.”  The global 
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distribution and molecular characteristics of W from 1970-2014 is described with emphasis on 
the emergence of endemic and epidemic W ST-11 disease since 2000.  
2.3 MOLECULAR CHARACTERISTICS OF GROUP W 
Multilocus sequence typing (MLST), which is based on sequencing DNA fragments of 7 
housekeeping genes, is the method of choice for determining the genetic lineage of N. 
meningitidis.25 Strains of the same sequence type (ST) share a common lineage and closely 
related STs are grouped under the same clonal complex (cc).  Historical sporadic W strains 
mostly belonged to ST-22, ST-174, and less often ST-11 clonal complexes. Following the Hajj 
2000 epidemic, ST-11 became the predominant W lineage globally and the only lineage 
associated with epidemic disease while sporadic W cases caused by other clonal complexes have 
persisted at low levels globally.30,42 
Outer membrane protein (OMP)genes (porA, porB, fetA): PorA and PorB are important 
virulence determinants and the basis of serologic classification of meningococci. The porA 
genotype based on sequence variation within two variable regions, VR1 and VR2, combined 
with MLST is a very powerful tool for surveillance. The porB and fetA  genotyping schemes are 
often used to further characterize invasive meningococcal strains.5 W ST-22 and ST-174 isolates 
have marked variability in their OMP allelic profiles consistent with non-clonal sporadic disease 
incidence. Conversely, the W ST-11 lineage has a remarkably stable outer membrane allelic 
profile P1.5,2:F1-1:2-2 (PorA VR1,VR2:FetA:PorB) despite global spread and different 
epidemiologic patterns over four decades.  
Factor H binding protein (FHbp) is a surface protein that helps meningococci evade innate host 
immunity by binding human complement factor H and is also one of the antigens of 
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polysaccharide capsule-independent vaccines that have been developed for prevention of group 
B infection.26 There is marked variability in the fHbp gene among W ST-11 strains globally. 
Endemic W ST-11 strains from Chile in 2012 and UK from 2010-2014 shared FHbp protein ID 
22 (variant group 2); Hajj related W ST-11 isolates from the UK 2000-2002 had FHbp 9 (variant 
group 1), while FHbp 23 and 9 were most common in W from the meningitis belt.   
 
Pulse field gel electrophoresis (PFGE) is often used in epidemiologic investigations to 
discriminate outbreak strains from genetically similar meningococcal strains unrelated to the 
outbreak. In a molecular epidemiologic study,45 six of 19 (32%) sporadic pre-Hajj W ST-11 
isolates were indistinguishable by PFGE from the Hajj clone with remaining 13 isolates having  
>85% PFGE similarity to the Hajj clone. Sporadic non-Hajj related W ST-11 from Younde, 
Cameroon in 1999-2000 also had only 1-2 band differences from Hajj clone by PFGE.15 Thus, 
PFGE discriminates different W lineages but is less discriminatory for epidemic and sporadic W 
ST-11 strains. In spite of this limitation, PFGE has been utilized to describe W strains as likely 
descendants of the Hajj clone. 
 
16S ribosomal RNA gene (16S) sequencing showed promise in discriminating the Hajj clone 
from sporadic W ST-11. The Hajj clone contained 16S type 31 while sporadic W ST-11 had 16S 
types 13 and 14.42,45  
 
As a result of increased availability and reduced costs, whole genome sequencing (WGS) data 
are now publically available for several hundreds of genomes.  In  a genomic comparison of W 
ST-11 isolates collected from UK in 2010-2013 and earlier Hajj-related UK isolates from 2000-
2002, over 200 allelic gene differences were identified.3 This study illustrates how in-depth 
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WGS analyses combined with epidemiological data could potentially illuminate the genetic basis 
of W ST-11 lineage emergence and virulence. 
 
“Capsular switching,” refers to the expression of a different polysaccharide capsule through 
allelic exchange of capsular genes. This phenomenon has been linked with an increased 
incidence of meningococcal disease.34,36 Surveillance studies have demonstrated that capsular 
switching is present in a substantial minority of invasive meningococcal disease isolates. 35,36 
Before 2000, the ST-11 genetic lineage was most commonly associated with invasive group C 
strains.59 This observation suggested that W ST-11 strains arose through C→W capsular switch, 
although the true direction of the genetic exchange is unknown.  
2.4 GLOBAL INCIDENCE OF GROUP W 1970 – 1999  
Capsular group W was associated with sporadic IMD cases globally in the 1970s through the 
mid-1990s. Active surveillance in the United States identified W in 2-4% of invasive 
meningococcal isolates from 1992-1998.38 Likewise in Canada W caused 3-6% of annual 
reported IMD cases in 1997-1999. 39 In the meningitis belt, W ST-11 was identified in 3.1% of 
349 endemic meningococcal disease strains from Senegal and Niger in 1981-1982 and 7.3% of 
41 strains from the Gambia. In 1992-1995, an unexpectedly high proportion of W ST-11 (43%) 
was observed in 14 endemic case isolates in Gambia and Mali.41 In Brazil, W represented <2% 
of all meningococcal disease isolates from 1990-2001.42 Lemos et al42 reported an increase in W 
ST-11 from 35% of 63 isolates in 1990-1995 to 80% of 56 isolates in 1996-1999 in Brazil. In the 
same period, a decline in W ST-174 occurred from 52% to 16% (Figure 3). All 67 W ST-11 
strains from Brazil in 1990-1999 were indistinguishable from the Hajj clone by porA and fetA 
genotyping but differed from the Hajj clone by both16S and PFGE.42 Strains genetically similar 
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to the Hajj clone were also identified in the 1990s in Taiwan,63 UK, France61 and Sweden.58 In 
England and Wales, average annual W cases increased to 42 cases/year in 1996/97-1998/99 
compared to 18 cases/year in 1993/94-1995/96.64  
 
In summary, W primarily caused sporadic disease globally. However, some surveillance data 
from the African meningitis belt, UK, Brazil and Taiwan suggest an increase in W ST-11 in the 
mid- to late 1990s, predating the Hajj 2000 epidemic.  
2.5 GROUP W INCIDENCE: 2000 AND BEYOND 
2.5.1 Saudi Arabia (Hajj) 2000-2001  
During the Hajj 2000 outbreak, over 400 cases were recorded among pilgrims and their close 
contacts across 16 different countries in Europe, Africa, Middle East, Southeast Asia and the 
United States (Figure 4).43 In 2001, a similar outbreak among pilgrims from Saudi Arabia 
occurred with 106 meningococcal cases reported that were genotypically indistinguishable from 
the 2000 Hajj clone. In 2001, a quadrivalent polysaccharide vaccine that covers W capsular 
antigen was made a visa requirement for all pilgrims traveling to Saudi Arabia, where no 
subsequent W outbreaks have been reported.44 
2.5.2 Middle East: endemic W following Hajj epidemic 
Following the epidemics in Saudi Arabia, W has emerged as a leading cause of endemic 
meningococcal disease across the Middle East. While Saudi Arabia witnessed a decline in 
meningococcal disease from 338 cases in 2000 to 6 cases in 2009, reports from Qatar, Oman and 
United Arab Emirates indicated that W was the most commonly identified meningococcal group 
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in 2001-2009.65 Epidemiologic data suggested that these endemic W cases represented spread 
and persistence of the Hajj clone.  
Laboratory surveillance of IMD strains from Egypt identified W ST-11 in 4.5% of 67 IMD 
isolates from 1998-2003.8 During 2005-2012 W ST-11 was identified as the leading cause of 
childhood acute bacterial meningitis in Turkey accounting for 38.1% of 333 confirmed cases.32 
These epidemiologic surveys illustrate the endemic nature of W ST-11 in the Middle East after 
the Hajj outbreaks. 
2.5.3 Africa: emergence of W ST-11 epidemics 
Cases of  W ST-11 among Hajj pilgrims and their contacts were reported across Africa in  
Morocco, Sudan, Chad, Central African Republic, and Burkina Faso in 2000 and 2001.7 In 2001, 
disease caused by W ST-11 was equally as common as group A in a non-representative sample 
of cases from outbreaks in Burkina Faso and Niger.50 The following year (2002), the largest 
known W epidemic occurred in Burkina Faso, with over 13,000 cases and 1,400 deaths. More 
than 80% of cases were by strains indistinguishable from the Hajj clone.  66  In 2003-2008, a 
significant proportion of endemic W disease in the meningitis belt was caused by ST-174 clonal 
complex.15,30 These data demonstrate the presence of other clonal W lineages in the meningitis 
belt of Africa post Hajj. Further W ST-11 epidemics were recorded across the meningitis belt in 
2009-20144,7,17 making W the most commonly isolated capsular group across the meningitis belt 
in 2010-2014 (Figure 5).  
 
The introduction of a highly effective group A polysaccharide-protein conjugate vaccine 
(MenAfriVac) in 2010 – 2014 led to a dramatic reduction in group A meningococci both in 
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disease cases and asymptomatic carriage51 that could lead to elimination of group A epidemics 
within the region, which underscores the importance of the recent emergence of W disease.  
Epidemic W ST-11 strains from the meningitis belt were indistinguishable from the Hajj clone 
by PorA and FetA genotyping despite having 1-4 PFGE band differences. 60  However, these 
strains had diverse FHbp protein profiles 67beyond the beyond the commonly tested OMP 
antigens. 
 
South Africa witnessed a doubling of meningococcal disease due primarily to an increase in W 
which caused 5% of meningococcal cases in 2000 and 62% in 2005. The majority of these cases 
(93%) belonged to W ST-11 similar to the Hajj clone.52  Similarly, meningococcal disease 
incidence attributed to W ST-11 increased in neighboring Mozambique from 2005-2008.68 
Again, it is not known whether endemic W ST-11 clusters in southern Africa represent global 
spread of the Hajj clone, regional spread of endemic strains from the meningitis belt or 
persistence of locally endemic strains. 
2.5.4 Europe: emergence of endemic W ST-11 clusters and persistence of sporadic W ST-22  
Cases of W ST-11 among returning pilgrims and their close contacts were reported across 
several European countries. 43 An overall increase in W disease occurred in France.  Of 101 W 
cases in 2001– 2002, 45% (45/101) belonged to ST-11 and were indistinguishable from the Hajj 
clone by serotyping and PFGE.61 Yet again, increase in W ST-11 in France could represent 
diversification of imported Hajj clone or expansion of locally endemic strains before the Hajj 
epidemic. In 2006-2008, W ST-11 cases declined and were replaced by ST-22.3 A cluster of 
imported W ST-11 cases from the meningitis belt was reported in France during 201247 further 
providing evidence of the continued potential for international spread of W ST-11.   
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A similar increase in W cases related to the Hajj outbreak was seen in the England and Wales 
2000-2002;64 W cases returned to pre-2000 levels in 2003 – 2008 and then increased again in in 
2009-2014, with 15% of all meningococcal disease cases in 2013-2014 being group W. Over 
67% of all W cases in the UK 2010-2013 belonged to ST-11 and were indistinguishable from the 
Hajj clone by PorA and FetA while ST-22 persisted as a cause of sporadic disease.3 Limited 
whole genome sequencing analysis revealed that recent endemic W ST-11 from the UK 2010-
2013 had phylogenetic differences from earlier W ST-11 strains related to the Hajj outbreak. 
Strains from the UK and Ireland (2009-2014) shared gene alleles corresponding to FHbp 22 as 
compared to the FHbp 9 found in the Hajj clone.3 
2.5.5 Latin America: Emergence of endemic W ST-11 clusters 
Southern Brazil, Argentina and Chile witnessed the emergence of W ST-11 as a major cause of 
endemic meningococcal disease after 2003. Case clusters first appeared in southern Brazil where 
W represented 17.5% of all invasive strains in 2003-2005 compared to 6.2% in 1995-2002. 69 In 
Argentina, W cases increased from 7% in 2006 to 50% of all isolates in 2008-2011.19 Similarly, 
the proportion of W ST-11 increased in Chile from 6.6% in 2010 to 58.3% in 2012 (Figure 6).48 
Similar to UK, W ST-11 from Chile also shared fHbp genotypes corresponding to protein ID 22. 
2.5.6 USA and Canada 
No increase in endemic W in the United States was observed despite presence Hajj related W 
ST-11 cases in 2000.45 W made up 2.3% (48/1979) of all strains isolated in the United States 
during 2000-201013,35 and belonged predominantly to ST-22 clonal complex with only 2 cases of 
W ST-11. However, a cluster of 14 W ST-11 cases was reported in 2008-2009 in Florida.46 Low 
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incidence rates of W disease (0.01-0.05 per 100,000) have persisted in Canada from 1990-2011 
accounting for 5% of all IMD cases.70  
2.5.7 Asia 
In Singapore, Hajj related and endemic W ST-11 cases were reported in 2000-2002. W ST-11 
cases have not been reported since 2003 suggesting disappearance of endemic W ST-11  in 
Singapore.71 In Taiwan 2000-2001, W ST-11 increased to 34 cases/year compared to 4 
cases/year in 1996-1999.63 Endemic W ST-11 cases emerged in China (2011-2012) where 24.4% 
(11/45) confirmed IMD in 2011 -2012) cases were W ST-11.49 Yet again, it is unclear whether 
W ST-11 in Taiwan and China represent expansion of local endemic strains or continued global 
spread of the Hajj clone.  
2.5.8 Australia and New Zealand 
In Australia, W caused 1.5-5% of annual IMD cases in 1997-2012. Australian W isolates were of 
diverse PorA genotypes including a few with P1.5,2 genotype similar to that found in the Hajj.72 
Disease caused by W continued to be rare in New Zealand, accounting for 3.5% of 700 reported 
IMD cases in 2008-2013.12 One case of W:P1.5,2:ST-11 was reported in New Zealand36 while a 
cluster of W:P1.7-2,4:ST-11 cases genetically distinct from Hajj clone was reported in 2003. 
This strain was shown to have arisen through capsular switching between locally endemic group 
C and a carriage group W strain. 
2.6 GEOGRAPHIC AND GENETIC ORIGINS OF THE HAJJ CLONE 
The Hajj clone represents clonal expansion of a historical capsular switch strain in circulation at 
least since the 1970s.45 Environmental factors unique to the Hajj pilgrimage may have facilitated 
emergence of the W ST11 Hajj clone. 59 The Hajj, an annual gathering of over 2 million people 
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from around the world is an ideal setting for the selection and rapid global dissemination of 
virulent meningococci. For example, in 1987, a Hajj-related meningococcal outbreak facilitated 
the spread of virulent group A ST-5 meningococci from south Asia to sub-Saharan Africa.44 It is 
hypothesized that the polysaccharide group A/C vaccine requirement for Hajj pilgrims in the 
1990s lead to selection of W capsular switch due to vaccine-induced immunologic pressure.  
The W ST-11 Hajj clone and its descendants may have subtle genetic changes that cannot be 
detected by traditional molecular methods.  Even small genetic changes in key virulence genes 
can lead to significant increase in transmission efficiency and virulence potential.62 Point 
mutations and/or recombination event(s) can differentiate the W ST-11 Hajj clone from endemic 
W ST-11. Detailed characterization of a global collection of meningococcal strains using whole 
genome sequencing is needed to discern genetic and epidemiologic relatedness between W ST-
11 strains. Limited surveillance of meningococcal disease and carriage strains in many regions in 
the decade before the Hajj epidemic makes accurate assessment of geographic origins of the Hajj 
clone difficult.  
 
Although epidemic W ST-11 IMD began with the 2000 Hajj outbreak, surveillance data showed 
an upward trend in W ST-11 sporadic cases in the mid to late 1990s in the meningitis belt,41,57 
Brazil,42 UK, and Taiwan.63 Also, the southern cone of Latin America, one of the regions facing 
recent emergence of W ST-11 witnessed no Hajj or other travel related W ST-11 cases making it 
more likely that W ST-11 emergence in the region represented regional expansion of rare 
sporadic W ST-11 strains. These studies suggest multifocal emergence of W ST-11 clusters some 
of which may be unrelated to the Hajj.60  
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2.7 CONCLUSION 
W has emerged during the past 15 years as an important global cause of meningococcal disease. 
The recent success with the control of MenA disease in the meningitis belt has resulted in the 
fact that W is now the predominant cause of meningococcal disease in the region. This, in 
combination with the emergence of disease caused by capsular groups X and C, underscore the 
need for polyvalent vaccines for the meningitis belt. Meningococcal disease surveillance on a 
global scale and broader application of whole genome characterization will improve our 
understanding of the factors contributing to the continued spread of the Hajj clone and the 
evolution of other W lineages.  
Funding: None 
Conflicts of Interest: All authors have no conflicts of interest.  
 
Figure 3: Molecular typing of invasive capsular group W N. meningitidis in Brazil, 1990-2005. 
 Based on data from Lemos et al42 
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Figure 4: Global spread of capsular group W ST-11 meningococcal disease case clusters and 
epidemics, 2000-2014.    
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Figure 5: Distribution of capsular groups among confirmed invasive meningococcal disease 
cases, meningitis belt 2006-2014.  
(source: World Health Organization, www.who.int/csr/disease/meningococcal/en/ ). 
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Figure 6: Molecular characterization of invasive meningococcal strains, Chile 2010-2011.54 
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3.1 ABSTRACT 
Neisseria meningitidis is a leading bacterial cause of sepsis and meningitis globally with 
dynamic strain distribution over time. Beginning with an epidemic among Hajj pilgrims in 2000, 
serogroup W (W) sequence type (ST) 11 emerged as a leading cause of epidemic meningitis in 
the African ‘meningitis belt’ and endemic cases in South America, Europe, Middle East and 
China.  Previous genotyping studies were unable to reliably discriminate sporadic W ST-11 
strains in circulation since 1970 from the Hajj outbreak strain (Hajj clone). It is also unclear what 
proportion of more recent W ST-11 disease clusters are caused by direct descendants of the Hajj 
clone. Whole genome sequences of 270 meningococcal strains isolated from patients with 
invasive meningococcal disease globally from 1970 to 2013 were compared using whole genome 
phylogenetic and major antigen-encoding gene sequence analyses. We found that all W ST-11 
strains were descendants of an ancestral strain that had undergone unique capsular switching 
events. The Hajj clone and its descendants were distinct from other W ST-11 strains in that they 
shared a common antigen gene profile and had undergone recombination involving virulence 
genes encoding factor H binding protein, nitric oxide reductase, and nitrite reductase. These data 
demonstrate that recent acquisition of a distinct antigen-encoding gene profile and variations in 
meningococcal virulence genes were associated with the emergence of the Hajj clone. 
Importantly, W ST-11 strains unrelated to the Hajj outbreak contribute a significant proportion of 
W ST-11 cases globally. This study helps illuminate genomic factors associated with 
meningococcal strain emergence and evolution. 
 Keywords: Hajj clone, invasive meningococcal disease, W135, whole genome sequencing, 
virulence factors, FHbp 
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3.2 RESEARCH IN CONTEXT 
Neisseria meningitidis, a bacterial cause of frequently fatal brain (meningitis) and blood stream 
(sepsis) infections, has variable strain distribution over time. Serogroup W sequence type 11 (W 
ST-11) lineage is associated on one hand with strains causing only rare (sporadic) disease cases, 
and the Hajj clone – a major global cause of epidemic and endemic meningococcal disease. In 
this study we analyzed complete genome sequences of a global collection of 270 W ST-11 
isolates causing meningococcal disease from 1970-2013. The Hajj clone acquired novel gene 
sequences within genes involved in nitrogen metabolism (nitrogen oxide reductase, nitrite 
reductase) and evasion of human immune response (factor H binding protein).These genes may 
be the cause of increased virulence of the Hajj clone and can be used to trace continuing spread 
of the clone. These results shed light on mechanisms of meningococcal strain emergence.  
3.3 INTRODUCTION 
Neisseria meningitidis is a major global cause of meningitis and sepsis with large variations in 
disease incidence rates and strain distribution globally.1 Incidence rates range from 0.5-15 cases 
per 100,000 population across most global regions. Very high incidence rates of 100-1000 per 
100,000 are witnessed during occasional epidemics across 21 countries7 in Africa collectively 
referred to as the ‘meningitis belt.’8 Meningococci are classified into serogroups based on 
biochemical properties of their polysaccharide capsule – the primary determinant of 
meningococcal virulence and major vaccine target. Serogroups A, B, C, W (formerly W-135) 
and Y cause almost all invasive disease cases. Other virulence determinants are 
lipooligosaccharide and several outer membrane proteins. Multilocus sequence typing (MLST),25 
based on DNA sequence of seven housekeeping genes, is used to classify meningococci into 
lineages (sequence types, ST). Closely related STs are termed ‘clonal complex.’  
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Outer membrane proteins, porins A and B (PorA, PorB) and iron-regulated enterobactin (FetA) 
are used for “fine typing” of meningococcal isolates while factor H binding protein (FHbp), 
Neisserial adhesion A (NadA) and Neisserial heparin binding antigen (Nhba) are components of 
capsule-independent vaccines developed for prevention of serogroup B disease. Meningococci 
have a very plastic genome as a result of frequent acquisition of genetic material from other 
Neisseria or more distant bacterial species through recombination. Recombination involving 
major outer membrane antigen genes - “antigenic shift” has been linked to increased incidence of 
meningococcal disease. Capsular switching – acquisition of novel capsule specific genes through 
recombination has also facilitates the emergence and persistence of virulent meningococcal 
lineages. Through capsular switching, defined as presence of different capsular phenotypes 
within the same clonal complex, meningococcal strains belonging to virulent lineages may 
escape vaccine induced immunity.  
In the 1970s to 1990s, serogroup W was a rare cause of meningococcal disease. In 2000, the first 
recorded serogroup W meningococcal disease outbreak occurred during the annual Hajj 
pilgrimage in Mecca, Saudi Arabia.16,43 The Hajj outbreak strain, referred to as the Hajj clone, 
was characterized as belonging to the hypervirulent sequence type (ST)-11 genetic lineage and 
having the PorA antigen-encoding  gene type P1.5,2.45 Since 2000, W ST-11 strains that are 
genetically similar to the Hajj clone have caused large epidemics in the African meningitis 
belt17,66,73 and have caused case clusters and smaller outbreaks in  South Africa,52 China,49 
Taiwan,63 Brazil,42 and most recently in Argentina,53 Chile54 and the United Kingdom.3  
In the 1960s-1980s more than 90% of ST-11 strains expressed serogroup C capsule.59 As a 
result,  W ST-11 is thought to have emerged from serogroup C ST-11 lineage through capsular 
switching though the direction of capsular switching has not been established.59 The Hajj clone 
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was highly similar by most molecular typing techniques including pulsed field gel 
electrophoresis (PFGE), PorA and FetA genotyping to historical rare sporadic group W ST-11 
strains isolated globally from 1970-1999.45,57,61 These “pre-Hajj” strains were distinguished by 
16S ribosomal RNA (rRNA) genotyping  as 16S type 13 and type 14 compared to type 31 
associated with the Hajj clone.45 The high genetic and antigenic similarity between the Hajj 
clone and pre-Hajj W ST-11 strains by traditional molecular techniques markedly contrasts with 
the abrupt and dramatic changes in the epidemiology of W ST-11 that began with the Hajj 
outbreak in 2000.59 There is a need for molecular surveillance laboratories to reliably identify 
epidemic from locally endemic sporadic strains. 
In a recent study, we compared capsular gene sequences from the Hajj clone and 24 other 
invasive W ST-11 strains isolated from 1970-2012.74 Phylogenetic and BLAST analyses against 
a database of over 2300 genome sequences demonstrated that the Hajj clone and 24 other 
invasive W ST-11 strains shared identical capsular recombination events, with a sporadic group 
W strain and Y ST-23 as the most likely donor lineages into a serogroup C ST-11 strain.74 Taken 
together, these studies suggest that historical sporadic W ST-11 strains and the Hajj clone have a 
common origin and likely emerged from a capsular switching event in a single ancestral C ST-11 
strain. Furthermore, these studies suggested that genetic differences outside the capsule region 
may be responsible for increased virulence seen in the Hajj clone when compared to historical 
sporadic W ST-11 strains.  
Whole genome sequencing (WGS) could potentially illuminate genetic differences not detectable 
by older genotyping techniques that could account for the observed epidemiologic differences 
between W ST-11 strains. We analyzed whole genome sequencing (WGS) data from invasive 
serogroup W ST-11 strains isolated globally from 1970-2013 to generate a model of W ST-11 
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evolution and global spread. We postulated that subtle genetic variations through recombination 
and/or mutation, outside of the capsule gene cluster may distinguish these W ST-11 strains and 
could explain the dramatic emergence and increased virulence of the Hajj clone. We identified 
genomic markers that are distinct from the Hajj clone, traced continued global spread of the Hajj 
clone, and interestingly, found that some of the current W ST-11 case clusters are caused by W 
ST-11 strains that are not direct descendants of the Hajj clone. 
3.4 METHODS 
Strain selection: We analyzed 270 Neisseria meningitidis serogroup W ST-11 genomes isolated 
from disease cases over four decades (1970-2013). Twenty-six genomes were newly sequenced 
while 244 genome sequences were identified from public databases (Table 2). All 26 newly 
sequenced genomes including 14 genomes that were part of the Genomic Sequencing Center for 
Infectious Disease (GSCID, gscid.igs.umaryland.edu/) project are made publically available in 
both PubMLST (pubmlst.org/neisseria/) and  GenBank databases.  In the PubMLST database, 
273 genome sequences were designated serogroup W ST-11 by the end of June 2014, of which 
31 genomes were excluded because they had missing information in at least one of six antigen 
gene alleles. Two genomes were obtained from Neisseria Base (nbase.biology.gatech.edu/).31,75  
Strain classification: W ST-11 invasive meningococcal strains were classified as isolated before, 
during or after the Hajj 2000 outbreak (Figure 7). Pre-Hajj strains (n = 13) were isolated globally 
from 1970-1999, the Hajj clone (n = 1) (Strain ID: M7124) was isolated in Saudi Arabia during 
the Hajj outbreak in 200045, post-Hajj (n = 256) were isolated during 2000 – 2013. All 270 whole 
genome sequences were characterized using antigen-encoding gene profiles and presence of 
genomic regions associated with allelic exchange. Forty-eight isolates representative of the 
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antigen-encoding gene and geographic diversity of all 270 strains were selected for whole 
genome phylogenetic analyses. 
Whole genome sequencing, assembly and genome annotation: A total of 26 W ST-11 isolates 
were newly sequenced using Pacific Biosciences RS II (PacBio, www.pacificbiosciences.com) 
Single Molecule Real Time (SMRT) sequencing (n = 7), paired-end Illumina HiSeq only 
(Illumina, www.illumina.com, n = 10), paired-end Illumina and Roche 454 (454.com/) 
pyrosequencing ( Illumina+454, n = 3) and Life Technologies (www.lifetechnologies.com) Ion 
Torrent PGM sequencing (n = 9) platforms. Library preparation and sequencing were done 
according to manufacturer protocols. Four out of 7 isolates sequenced using PacBio had 
previously been sequenced using Illumina+454 (M7124) or Ion Torrent (NM3682, NM3686, 
NM3687 ). M7124 was re-sequenced using PacBio to provide very high quality Hajj reference 
genome sequence.  
De novo assembly was done using Hierarchical Genome Assembly Process (HGAP) v4.0 for 
PacBio, Celera v7.0 for Illumina/454 and Mira 3.0 for Ion Torrent with default settings and 
assembly qualities were checked as described in Supplementary Methods.76,77 Contiguous 
genomic DNA sequences (contigs) from de novo assemblies were annotated on RAST and IGS 
annotation servers.78 Assembled contig files were downloaded from public databases for the 
remaining 244 genome sequences. 
Whole genome alignment and phylogenetic analyses: Forty-eight representative W ST-11 strains 
underwent whole genome phylogenetic analyses. Core genome alignment of 1,014,185 sites was 
generated using Mauve v2.379 and a Maximum-Likelihood phylogenetic tree was constructed 
using general time reversible model with invariant sites (GTR+Γ+I) with 100 bootstrap replicates 
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using PhyML v3.0.80 The effect of recombination on phylogenetic relationships was assessed 
using SplitsTree v481 and ClonalFrame v1.2.82 ClonalFrame is a phylogenetic reconstruction 
method that determines phylogenetic relationships between bacterial strains after detecting and 
accounting for recombinant sequences based on a coalescent model of evolution. 
Antigen gene allele designations for full length porA, porB, fetA, nadA, nhbA and fHbp genes 
were obtained by comparing assembled contigs to reference alleles downloaded from the 
Neisseria PubMLST database (pubmlst.org/).31 Phylogenetic trees of catenated, aligned antigen-
encoding gene sequences were constructed using ClonalFrame and phylogenetic trees were 
visualized on CLC Genomics workbench v7 (www.clcbio.com) and MEGA v5.2.83 
Gene gain/loss: Annotated gene sequences for the Hajj reference strain, M7124, were compared 
to W ST-11 strains using BLASTn with a cut-off of 70% alignment coverage and 70% identity. 
Universally present genes were aligned using MAFFT84 v7 and Maximum-Likelihood tree was 
constructed as described above.  
Single nucleotide polymorphism (SNP) analysis: Raw sequence reads of 23 W ST-11 isolates for 
which we have short read sequence data were aligned to the Hajj reference genome M7124 using 
BWA v0.685. Aligned reads were indexed, sorted and filtered using VCFtools v0.1 with default 
options. All insertions and deletions (indels), diploid SNPs and SNPs with phred-like quality 
score, Q < 30 were excluded. Hajj specific SNPs were defined as those SNPs found in all Hajj 
cluster strains, but not non Hajj-cluster strains. Hajj cluster strains were defined as all strains 
phylogenetically and antigenically very closely related to the Hajj clone. We determined which 
discriminatory SNPs were acquired by recombination as opposed to spontaneous mutation by 
phylogenetic and BLASTN analyses of genomic sequences adjacent each Hajj specific SNP.  
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Bioinformatics analyses were done on BioLinux 7 server86 and Windows 7 computing 
environments. 
Multilocus sequence typing (MLST) and outer membrane protein (OMP) gene sequencing: 
MLST and OMP sequence typing of the porA VR1, VR2, and fetA VR gene fragments were 
performed as described in Supplementary Methods.  
16S rRNA gene sequencing: PCR amplification and sequence analysis of the 16S rRNA genes 
were performed using modifications of published methods42,87 as described in Supplementary 
Methods.  
Funding: This study was supported by a career development award to Dr. Harrison, NIAID (K24 
AI52788) and by a grant from the University of Pittsburgh Department of Epidemiology Small 
Grants Program. This project has also been funded in part with federal funds from the National 
Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health 
and Human Services under contract number HHSN272200900009C. 
Role of funding source: Funding sources played no role in study design; in the collection, 
analysis, and interpretation of data; in the writing of the report; and in the decision to submit the 
paper for publication 
3.5 RESULTS 
The Hajj clone (strain ID: M7124), and six other W ST-11 strains that were sequenced using 
PacBio provided very high quality reference sequences (Table 2), with excellent resolution of 
capsular genes and other highly repetitive genomic regions.  
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W ST-11 strains in this study were closely related to serogroup C ST-11 strains and clustered 
into two main groups based on genetic relatedness to the Hajj clone. Out of 270 total strains, 125 
(46.3%) were most closely related to the Hajj clone based on antigen-encoding gene profiles 
(Figure 8), presence of recombinant alleles (Table 1, Figures 20-23) and whole genome 
phylogenetic analyses (Figures 9 and 24). We collectively refer to these strains as Cluster 1 (Hajj 
cluster). All strains in this cluster were isolated during or after the Hajj 2000 epidemic (post-Hajj 
strains). Remaining 145 strains were more heterogeneous having antigen-encoding gene, 
phylogenetic and SNP differences within key virulence genes compared to M7124 and were 
collectively referred to as Cluster 2 strains. This cluster included both historical W ST-11 strains 
isolated before 2000 (pre-Hajj strains) and post-Hajj strains (2000-2013). 
3.5.1 Phylogenetic analyses 
Phylogenetic trees constructed using three different methods, Maximum Likelihood, SplitsTree 
and ClonalFrame consistently discriminated Cluster 1 from Cluster 2. Phylogenetic analyses of 
aligned whole genome sequences (Figures 9 and 24) and concatenated antigen-encoding gene 
sequences (Figure 8) demonstrated that several strains (Cluster 1/Hajj cluster) were nearly 
identical to M7124 suggesting that these strains were direct descendants of the Hajj clone. The 
other strains (Cluster 2) were phylogenetically diverse and included a combination of recent and 
historical strains from the 1970s and 1980s that were most closely related to serogroup C ST-11 
strains. SplitsTree phylogenetic network constructed from aligned core genome sequences 
support a clonal phylogenetic relationship between Cluster 1 strains (Figure 9). Also, a 
comparison of SNPs in 23 W ST-11 strains relative to M7124  showed that Cluster 1 strains had 
fewer SNP differences than Cluster 2 strains, which collectively support indicate that Cluster 1 
(Hajj cluster) strains represent clonal expansion within the W ST-11 lineage. Furthermore, these 
  
37 
results demonstrate that many recent W ST-11 case clusters are more closely related to pre-Hajj 
sporadic strains and are unlikely to be direct descendants of the Hajj clone. 
Genomic differences between the Cluster 1 and Cluster 2 strains were further explored by 
mapping the genomic locations of Hajj specific SNPs among 23 selected strains. Of 48 Hajj 
specific SNPs, 46 were located in four genomic regions that ranged in size from 1·2-4·3 kb. 
Phylogenetic and BLAST analyses suggest these genomic regions were acquired through 
homologous recombination (allelic exchange) [Figures 20-23]. Two of these recombinant 
regions encode known meningococcal antigens and/or virulence proteins – factor H binding 
protein (fHbp), nitric oxide reductase (nor), and nitrite reductase (aniA). 
To explore the presence of these identified recombinant regions in all 270 strains in our 
collection, we queried nucleotide sequences from these recombinant regions in M7124 against 
assembled contigs from all 270 genomes using BLASTN with 99% sequence identity and 
coverage. All four recombinant regions present in the Hajj clone were also found in 95·1% 
(118/124) of Cluster 1 strains. Six other Cluster 1 strains from South Africa 2005-2013 (21583, 
29326, 29336, 29387, 29402 and 29393) had allelic profiles within one of four recombinant 
regions that were different from Hajj clone alleles. No Cluster 2 strain had a sequence closely 
matching any of the four recombinant regions associated with the Hajj clone. These results 
demonstrate that these genomic regions represented areas with allelic replacement through 
recombination likely involving donor sequences from meningococci outside ST-11 lineage and 
commensal Neisseria species.  
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3.5.2 Antigen-encoding genes  
Cluster 1 (Hajj cluster): The Hajj clone and 43% (116/270) of all W ST-11 strains in this study 
had an identical antigen-encoding gene profile: porA 1, porB 1, fetA 13, nadA 5, nhba 72 and 
fHbp 9. Strains with this profile were isolated from the meningitis belt in 2000 – 2005, Mauritius 
(2001), South Africa (2003 – 2013), United States (2000) and the UK (2000 – 2004, 2007, 
2011). The Hajj clone antigen-encoding gene profile is characterized by a unique fHbp allele 9 
(FHbp peptide 9, variant group 1/sub-family B). This fHbp allele was present only in Cluster 1 
strains and not in sporadic pre-Hajj W ST-11 strains. fHbp allele 9 was most likely acquired 
through allelic exchange within one of the four recombinant regions identified earlier (Figures 
20-23). Nine other strains all isolated from South Africa in 2010-2013, differed only at the fetA 
gene compared to the Hajj clone, these strains were classified as Cluster 1 strains based on whole 
genome phylogenetic analysis and shared recombinant alleles with the Hajj clone. 
Cluster 2: Antigen-encoding gene profiles (Figure 8) were more heterogeneous within Cluster 2 
with two different alleles each for nadA and nhba and 8-11 different alleles for porA, porB, fetA, 
and fHbp genes. There were 33 different allelic combinations within Cluster 2 with 67.6% 
(98/145) having one of three predominant porA/porB/fetA/nadA/nhba/fHbp allelic profiles: 
1/244/13/5/17/22, 1/311/13/5/17/160, and 1/1/13/3/17/22. None of the pre-Hajj strains shared an 
identical antigen-encoding gene profile with the Hajj clone. The fHbp locus was the most 
divergent between Cluster 1 and Cluster 2. The most common fHbp allele in Cluster 2 strains 
was allele 22 belonging to variant 2/family A present in 80.2% (117/145). None of the Cluster 2 
strains had the Hajj clone fHbp gene allele. The remaining five antigen-encoding genes – porA, 
porB, fetA, nadA and nhba genes–were more closely related to the Hajj clone alleles.  
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Strains in Cluster 2 were also geographically and temporally diverse, with W ST-11 strains 
isolated from the UK from 1970-1975 and Netherlands in 1985 being antigenically most closely 
related to the serogroup C ST-11 reference strain FAM18 (Figure 2, 3A-C, Supplementary Figure 
3A-B). Five of nine strains from the meningitis belt isolated in 2000-2005 and 72.4% of 98 post-
Hajj strains from South Africa (2003 – 2013) had the Hajj related antigen-encoding gene profile. 
In contrast, only one of three strains from the USA (2000, 2008-2009) and none of the five post-
Hajj strains from Brazil and Chile had the Hajj related antigen-encoding gene profile. In the UK, 
strains with identical antigen-encoding gene profile to the Hajj clone predominated in 2000 – 
2004 (97.8% of 45 strains) but were uncommon during 2005 – 2013 (3.3% of 90 strains). These 
data are consistent with antigenic diversification of W ST-11 strains presumably following an 
ancestral C to W ST-11 capsular switch, and subsequent emergence of the Hajj cluster from 
within Cluster 2 strains. 
Gene content: All annotated genes within the M7124 genome were found in at least one pre-Hajj 
strain, suggesting that the Hajj clone did not acquire additional genes but gained novel alleles by 
recombination.  
16S Ribosomal RNA gene (16S) typing: 16S rRNA type 31 was shared by the Hajj clone and six 
out of eight Cluster 1 strains while 14 of 16 Cluster 2 strains (87.5%) strains had 16S type 13.   
3.6 DISCUSSION 
In this study, we demonstrate that W ST-11 strains are closely related to serogroup C ST-11 N. 
meningitidis and likely arose from a single ancestral capsular switching event. We also 
demonstrate that the emergence of the Hajj clone in 2000 was caused by a meningococcal strain 
that was distinct from other circulating serogroup W ST-11 strains. This conclusion is supported 
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by the congruent results from detailed whole genome phylogeny, antigen-encoding gene 
characterization, and identification of recombinant virulence gene alleles that were unique to the 
Hajj clone. This study clarifies the recent emergence of serogroup W ST-11 disease globally, 
which, based on previous limited genetic analyses, appeared to be caused by highly-related 
strains. To our knowledge, this is the first detailed genomic analysis of serogroup W ST-11 
strains that have emerged globally as a major virulent meningococcal lineage.  
Based on these results and those from previous studies,45,74 we propose a model whereby W ST-
11 diverged from a C ST-11 ancestral strain through capsular switching before 1970 (Figure 10). 
From the 1970s onward, W ST-11 strains disseminated to cause sporadic disease and case 
clusters globally (Cluster 2). Cluster 1 strains (Hajj cluster) evolved from sporadic Cluster 2 
strains through allelic exchange within four recombinant regions two of which encode FHbp, 
nitric oxide reductase and nitrite reductase.  This model supports global co-circulation of both 
Cluster 1 (Hajj cluster) and Cluster 2. 
Sequence variation within the fHbp gene can potentially be used as a marker to identify the Hajj 
clone and closely related Cluster 1 strains. For example, a study of fHbp gene profiles from 47 
endemic W ST-11 strains from 16 African countries isolated from 1980 – 2006 demonstrated 
that 34% of the strains shared the Hajj clone fHbp allele 9.67 Also, all W ST-11 strains with the 
Hajj clone fHbp allele 9 (variant family 1) were isolated after the Hajj 2000 epidemic while fHbp 
alleles belonging to variant family 2 and 3 were identified both before and after Hajj 2000. These 
findings are consistent with our results and support our evolutionary model.  
Since 2001, Hajj related and endemic non Hajj W ST-11 strains have co-circulated across the 
meningitis belt. In 2002, the largest recorded epidemic of W ST-11 occurred in Burkina Faso 
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with 12,000 cases and 1,400 deaths.88 It was generally believed that the Burkina Faso and other 
African W ST-11 epidemics were caused by direct spread of the Hajj clone. However, three 
Burkina Faso strains from 2001 – 2002 analyzed in this study all had antigen-encoding gene and 
other genomic markers consistent with non Hajj-cluster endemic W ST-11 strains. Additionally, 
Pajon et al67 reported that 76.5% (17/ 22) W ST-11 strains from Burkina Faso 2001 – 2003 had  
fHbp genotypes associated with endemic non Hajj strains. Epidemics of W ST-11 subsided in the 
meningitis belt from 2003-2009 despite persistence of small case clusters but resurfaced in 2010 
– 2013.73,89 Detailed antigenic and genomic characterization of more recent W ST-11 strains 
from the meningitis belt will be needed to monitor the continued evolution of the Hajj clone and 
endemic W ST-11 strains.  
Outside the meningitis belt, serogroup W strains accounted for 62% of all invasive 
meningococcal disease strains in South Africa in 2005 compared to 5% in 2000, with 93% of W 
strains belonging to ST-11 lineage.90 Our study reveals that 71·4% of 98 South African W ST-11 
strains from 2003 – 2013 belonged to the Hajj cluster. These results are consistent with the 
finding that 85% of invasive W ST-11 strains isolated in South Africa in 2005 had the Hajj -
related fHbp allele 9.90 Taken together, these data show that the Hajj cluster strains were 
predominant in South Africa. In the UK, Hajj related W ST-11 strains predominated in 2000 – 
2004 but were replaced by endemic non Hajj strains thereafter.91 Likewise, our results suggest 
that the small case clusters of W ST-11 in the United States 2008-2009,46 and larger clusters in 
south Brazil 2003-2005,42 and Chile 2010-201254 represent the local spread of endemic strains 
with no evidence of direct spread of the Hajj clone.  
Gene sequencing for 16S ribosomal RNA was previously the most discriminatory test for 
differentiating the Hajj clone, which exhibited 16S type 31 compared to type 13 and 14 in 
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sporadic W ST-11 strains.45 However, our data demonstrate evolution of the 16S rRNA allele 
within strains linked to the Hajj outbreak and the presence of 16S type 31 in strains that are 
genetically unrelated to the Hajj clone.  
There are several hypotheses  that could explain  the emergence of the Hajj clone and subsequent 
W ST-11 outbreaks worldwide.59 FHbp is a major meningococcal antigen and a virulence 
determinant that is a component of vaccines developed for protection against serogroup B 
strains.  The introduction of a novel FHbp antigenic type into an immunologically naïve 
population may have played a part in the emergence of the Hajj clone. In support of this 
hypothesis, the fHbp allele 9 unique to the Hajj related strains, belongs to variant group 1/sub-
family B  and has limited immunologic cross reactivity with variant groups 2 and 3/sub-family 
A, which were prevalent among Cluster 2 strains.92,93 Similarly, antigenic shift was associated 
with increases in serogroup C and serogroup Y meningococcal disease in the U.S. in the 1990s.94  
Alternatively, the genomic changes we observed in the Hajj clone may be associated with 
increased virulence. For example, the nitrite reductase (aniA) gene – encoding a major outer 
membrane copper-containing protein, and the nitric oxide reductase (nor, sometimes referred to 
as norB) gene are both essential for overcoming oxidative stress and resistance to phagocytic 
lysis by macrophages.95 Also, N. meningitidis lacking the nor gene have been shown to survive 
poorly in human nasopharyngeal tissue.96 Together, these data suggest that allelic variation in 
key virulence determinants may have a potential contribution to W ST-11 emergence. Then 
again, the genomic events observed could simply be markers of other events that lead to 
changing epidemiologic behavior of W ST-11.  
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This study provides increasing evidence on the role of recombination in the emergence and 
persistence of meningococcal lineages and demonstrates the role of recombinant gene alleles in 
molecular epidemiologic typing of meningococcal isolates. We also add to the body of evidence 
showing the suitability of fHbp gene sequencing for routine meningococcal surveillance. A 
limitation of this study is incomplete data as a result of variations in meningococcal disease 
surveillance by country and over the study period particularly in the 1970s-1990s when 
serogroup W strains were thought to be less virulent than other meningococcal lineages.  
In summary, this study describes evidence of an ancestral capsular switching event and a model 
for the emergence, persistence and global spread of W ST-11 strains that are highly related to the 
Hajj 2000 outbreak strain. These data also demonstrate the co-circulation of W ST-11 strains that 
are phylogenetically and antigenically distinct from the Hajj clone and still cause disease in the 
African meningitis belt and globally. The emergence of the Hajj clone may have occurred 
because of the recent acquisition of a distinct antigen-encoding gene profile and genetic 
variations in meningococcal virulence genes.  
3.7 LEGENDS 
Table 1: Homologous recombination regions associated with Hajj specific SNPs. Start and end 
indicate up- and downstream recombination breakpoints. Numbers and annotations are relative to 
the Hajj clone reference strain, M7124. Known virulence genes are shown in bold. No. of SNPs - 
Number of highly discriminatory SNPs within genomic region. Closest match - Closest match 
based on BLASTn query on PubMLST database (pubmlst.org/neisseria/). 
Table 2: Characteristics of 26 meningococcal genomes sequenced in this study. 
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Figure 7: Flow chart showing how 270 invasive W ST-11 meningococcal strains were grouped 
based on date of isolation (epidemiologic classification) and the combined results of whole 
genome sequence analysis (genomic classification). All 270 strains were classified into Cluster 1 
and 2 based on antigen-encoding  gene analyses and presence of recombinant genomic regions. 
Several strains from each cluster were further analyzed by whole genome phylogenetic and Hajj 
specific SNP analyses as described in the Methods. 
Figure 8: Antigen-encoding  gene profiles of 270 invasive serogroup W and historical serogroup 
C ST-11 strains. On the left is ClonalFrame consensus tree constructed using concatenated full 
length antigen-encoding  gene sequences from porA, porB, fetA, nadA, nhba and fHbp genes. 
Color chart in the center depicts antigen gene allelic differences among W ST-11 strains 
compared to M7124 allele. Year(s) reflect earliest and most recent isolation dates for strains with 
the listed antigen-encoding gene profile; N: Total number of strains with listed antigen-encoding 
gene profile. Numbers in parentheses indicate total number of strains with identical antigen-
encoding gene profile to the adjacent strain for profiles shared by more than one strain. On the 
right, green open triangles mark Cluster 1 strains, red open squares mark Cluster 2 and blue open 
circles mark serogroup C ST-11 strains. Antigen-encoding  gene allele numbers were obtained 
from www.pubmlst.org/neisseria. Scale bar represents time (coalescent units).  
Figure 9: Core genome phylogenetic tree of serogroup W ST-11 and historical serogroup C ST-
11 N. meningitidis strains (A). A maximum likelihood phylogenetic tree was constructed from 
aligned universally present genome sequences with 100 bootstrap iterations using the General 
Time Reversible model, gamma distribution of rate variation with invariant sites (GTR+Γ+I). 
Scale bar represents phylogenetic distance. Tree is rooted using the serogroup B reference strain 
MC58 as outgroup (not shown). Bootstrap support values <60% are not shown. SplitsTree 
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phylogenetic network of generated from the alignment described above (B). In A-B above,  
several serogroup W ST-11 strains (Cluster 1) are phylogenetically very closely related to the 
Hajj clone reference strain M7124; remaining W ST-11 strains (Cluster 2) are phylogenetically 
diverse. 
Figure 10: Genomic model of  serogroup W ST-11 emergence and global spread. W ST-11 
lineage likely emerged from an ancestral serogroup C ST-11 strain through ‘capsular switching’ 
– recombination within the capsular gene cluster (cps) involving donor sequences from a 
sporadic W strain and Y ST-2374 with subsequent antigenic diversification giving rise to sporadic 
W ST-11 strains (Cluster 2). The Hajj clone (Cluster 1) emerged through recombination within 
antigen-encoding  and virulence genes fHbp, nor and aniA.      
Figures 20-23: Phylogenetic tree of Hajj cluster recombinant regions 1-4. Gene sequences 
involved in recombination are highlighted in blue; Numbers at the top of annotations represents 
genomic locations of recombinant regions within M7124 genome.   Maximum Likelihood trees 
with 500 bootstrap replicates were constructed using the Hasegawa, Kishino and Yano (HKY) 
model of evolution under uniform rate of substitution. 
Figure 24: Phylogenetic tree of serogroup W, C and B ST-11 strains in relation to other 
hyperinvasive meningococcal lineages. A maximum likelihood phylogenetic tree was 
constructed from concatenated 140,903 SNP positions among 153 meningococcal strains using 
the General Time Reversible model, gamma distribution of rate variation with invariant sites 
(GTR+Γ+I). Green triangles represent Hajj cluster (Cluster 1) W ST-11 strains, blue diamond 
represents Cluster 2, white diamonds and red squares represent serogroup C and B ST-11 
respectively. Scale bar represents phylogenetic distance.  
  
46 
3.8 AUTHOR CONTRIBUTIONS 
Conception of study hypothesis, aims and analytic plans: MMM, JWM, JGL, NLH, LHH. 
Acquisition and molecular characterization of meningococcal isolates: JWM, JOF, APSL, XW, 
LWM, LHH. Meningococcal genome sequencing, data analysis and interpretation: MMM, JWM, 
MGK, APSL, JOF, JCDH, XW, LWM, JGL, NLH, LHH. Initial draft and revision of study 
manuscript: MMM, JWM, MGK, JCDH, XW, LWM, JGL, NLH, LHH. Read and approved final 
manuscript: MMM, JWM, MGK, JOF, APSL, JCDH, XW, LWM, JGL, NLH, LHH. 
3.9 DECLARATION OF INTERESTS 
Dr. Harrison reports grants and personal fees from Sanofi Pasteur, personal fees from GSK, 
personal fees from Merck, personal fees from Novartis, personal fees from Pfizer,  outside the 
submitted work; and All relationships with industry were terminated before I became a voting 
member of the Advisory Committee on Immunization Practices on July 1, 2012. Dr Lemos 
reports travel grants and personal fees from Novartis, personal fees from Sanofi Pasteur , travel 
grants from GSK, outside the submitted work. Other co-authors have no interests to declare. 
3.10 ACKNOWLEDGEMENTS 
We thank Maria Brooks for thoughtful discussions about the study. We also thank Jessica 
Schlackman for DNA extraction and genotyping of bacterial strains and Jeremy Nelsen for 
assistance with bioinformatics analyses.  
This publication made use of the Neisseria Multi Locus Sequence Typing website (pubmlst.org/ 
neisseria/) developed by Keith Jolley and sited at the University of Oxford.31 The development 
of this site has been funded by the Wellcome Trust and European Union. 
  
47 
This publication also made use of the Meningitis Research Foundation Meningococcus Genome 
Library (www.meningitis.org/research/genome) developed by the Health Protection Agency, the 
Wellcome Trust Sanger Institute and the University of Oxford as a collaboration.  
 
 
Figure 7: Flow chart showing  classification of invasive W ST-11 meningococcal strains. 
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Figure 8: Antigen-encoding  gene profiles of 270 invasive serogroup W and historical serogroup 
C ST-11 strains.  
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Figure 9: Phylogenetic trees of serogroup W ST-11 and historical serogroup C ST-11 N. 
meningitidis strains.  
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Figure 10: Genomic model of  serogroup W ST-11 emergence and global spread.  
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Table 1. Homologous recombination regions associated with Hajj specific SNPs. 
 Genomic location of Hajj specific SNPs  
Recombina
nt  
region 
start end size 
(kb) 
No. of 
SNPs 
Annotations Closest 
match 
1 329041 330204 1.2 5 Phosphopantetheine 
adenylyltransferase, coaD;  
Ribosomal large subunit 
pseudouridine synthase D 
Neisseria 
cinerea 
2 628712 632970 4.3 13 fructose-bisphosphate aldolase, fba; 
Factor H binding protein, fHbp;  
glycoprotease family protein; 
ribosomal-protein-alanine 
acetyltransferase, rimI; 
uracil DNA glycosylase; 
Orotate phosphoribosyltransferase, 
pyrE; 
MJ0042 family finger-like domain 
protein; 
amino-acid N-acetyltransferase, argA 
Neisseria 
meningitidis 
serogroup B 
ST-639 (cc32) 
3 896826 900840 4.0 13 Argininosuccinate lyase, argH ; 
UTP-Glucose-1-phosphate uridyl 
transferase, galU; 
purine NTP pyrophosphatase, rdgB; 
dATP pyrophosphohydrolase, ntpA; 
inorganic pyrophosphatase, ppa 
Neisseria spp 
ST-6263 (cc -) 
4 1844312 1846343 2.0 15 Nitric oxide reductase, nor;  
Nitrite reductase, aniA 
Neisseria 
meningitidis 
ST-461 
(cc461) 
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4.1 ABSTRACT  
Neisseria meningitidis group W ST-11 is an important cause of meningococcal disease globally. 
ST-11 is a hypervirulent meningococcal lineage historically associated with group C capsule 
type and is believed to have acquired the W capsule through a C to W capsular switching event. 
We studied the sequence of capsule gene cluster (cps) and adjoining genomic regions of 525 
global W ST-11strains.We identified recombination breakpoints corresponding to two distinct 
recombination events within W ST-11. 1) An 8.4 kb recombinant region likely acquired from W 
ST-22 that includes the sialic acid transferase gene, csw resulted in a C→W change in capsular 
phenotype. 2) A 13.7 kb recombinant segment likely acquired from Y ST-23 lineage that 
includes 4.5kb of cps genes and 8.2kb outside the cps cluster and led to allelic changes in capsule 
translocation genes. A vast majority of W ST-11 strains (497/524, 94.8%) have identical or very 
closely related capsular allelic profiles. These data suggest that the W ST-11 capsular switch 
involved two separate recombination events and that current global W ST-11 meningococcal 
disease is caused by strains bearing this capsular switch.  
4.2 INTRODUCTION 
Polysaccharide capsule is the most important virulence determinant of Neisseria meningitidis, a 
normal commensal of the human nasopharynx2  that occasionally causes invasive meningococcal 
disease (IMD). Even though un-encapsulated meningococci are common in asymptomatic 
carriage, they are very rarely associated with IMD.97 This polysaccharide capsule is the target of 
capsule-specific vaccines and its biochemical and genetic properties form the basis of classifying 
meningococci into capsular groups (serogroups). Out of 13 capsular groups, groups A, B, C, W, 
X and Y cause almost all cases of IMD 2.   
  
54 
Capsular group W sequence type (ST) 11 evolved from a rare cause of meningococcal disease in 
the 1970s-1990s 41 to a leading cause of invasive meningococcal disease globally in 2000-2015 
3,73. Epidemic W ST-11, often referred to as the Hajj clone emerged in Mecca, Saudi Arabia 
among Hajj pilgrims and their close contacts in 2000 16. W ST-11 is a major global hypervirulent 
lineage responsible for large epidemics in the ‘meningitis belt’17,66 and high burden of endemic 
cases in Europe 3, Latin America 48 and the Middle East65. Whole genome phylogenetic studies 
suggest that recent global W ST-11 disease burden represents both continued global spread of the 
Hajj clone and persistence of endemic W ST-11 strains unrelated to the Hajj outbreak. 98,99  
N. meningitidis has high frequency of genetic change through homologous recombination that 
drives meningococcal genetic diversity and plays a role in the emergence and persistence of 
virulent strains 100. Capsular switching, acquisition of novel capsular genes, is one mechanism by 
which N. meningitidis may escape population immunity 34. Capsular switching is a relatively 
common phenomenon among invasive meningococcal isolates 35,36,101.  
The capsule gene cluster (cps), a 24 kb pathogenicity island, contains 5 gene regions involved in 
capsule synthesis, transport and assembly (cps regions A-E) 10. Region A contains genes that 
synthesize capsular polysaccharide and are capsular-group specific while conserved regions B 
and C are involved in capsule translocation. Groups B, C, W and Y have capsules containing 
sialic acid residues10,34. The sialic acid transferase gene, located in region A, dictates sialic acid 
linkage and thus determines group phenotype. Regions D and D’ are involved in 
lipopolysaccharide synthesis while the function of genes within region E as not been clearly 
defined. The genetic basis of capsular switching is homologous recombination involving allelic 
exchange of cps genes. For a recombination event to result in change of capsular phenotype, 
allelic changes must include region A genes, particularly the sialic acid transferase 34.  
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Historically, ST-11 was predominantly associated with virulent group C strains and W ST-11 is 
thought to have arisen from C→W capsular switching37,59 However, the genetic events 
associated with this C→W capsular switching have not been established. Furthermore, it is not 
established whether the Hajj clone underwent recombination event(s) that were distinct from 
those in W ST-11 strains causing rare sporadic disease cases that occurred before 2000. 
The purpose of this study was to analyze capsular gene sequences among meningococcal isolates 
from a global collection to define the capsular switching events that occurred in the W ST-11 
lineage.   
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4.3 METHODS 
Study isolates: A total of 529 serogroup W ST-11 whole genome sequences were identified from 
PubMLST (www.pubmlst.org/neisseria), a database that captures Neisseria genetic diversity by 
assigning allele numbers for all Neisseria genes. Four isolates (19369, 19377, 19379, and 19381) 
were excluded because they had missing data for a majority of cps alleles. Capsular contigs and 
allele designations for 525 isolates were included in the study. One of these isolates, M7124, 
identified in Saudi Arabia during the Hajj 2000 epidemic is a well characterized reference strain 
for the W ST-11 lineage and is used in this study as W ST11 cps reference genome.99 
Identification of recombination donors and breakpoints for M7124: To determine the 
organization of cps genes, contiguous nucleotide sequences (contigs) containing cps sequences 
were extracted for the Hajj clone reference strain, M7124.  
M7124 cps sequences were compared using SplitsTree81 phylogenetic networks and visual 
inspection of sequence alignments with previously described cps sequences for reference 
meningococcal strains 10. Also, potential recombination donor lineages were assessed by 
querying Neisseria genome sequences on PubMLST and GenBank databases to determine 
closest matches outside of the W ST-11 lineage. A strain was considered a potential donor for 
M7124 capsular genes if it had ≤1 nucleotide difference per 1000bp over a span of at least 2kb 
compared to M7124. Recombination breakpoints were identified from sequence alignments as 
points of abrupt change in sequence similarity between M7124 and a potential donor strain.  
Comparison of cps alleles within W ST-11 lineage: M7124 cps gene sequences were compared to 
524 W ST-11 strains with whole genome sequence data isolated from 21 different countries. 
Majority (93.3%, 489/524) were isolated in 2000 – 2014 with the remaining 35 isolated in 1970-
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1999. Most isolates were from in the United Kingdom (331/524, 63.2%), South Africa (116/524, 
22.1%) or the meningitis belt (34/524, 6.5%). Gene alleles were downloaded for sixteen cps 
genes (ctrA-G, cssA-C, csw, tex, galE, galE2, rfbC and rfbC2) that had complete sequences for 
≥80% of the study isolates. Allele information for rfbA and rfbB genes was excluded due to 
missing data among 91% (479/525) and 79% (416/525) of total isolates respectively. Also, gene 
elements not curated by PubMLST including insertion sequences, putative fragments in close 
proximity to insertion sequences and two pseudo-genes within region E were all excluded from 
further analyses. Over 70% of isolates (368/524) had complete sequence data for all 16 cps 
genes, 22.3% (117/524) had missing data for one or two genes while 39 (7.3%) had missing data 
for three to five genes. GalE2 (99/524, 19.9%), and galE (94/524, 17.9%) genes had the highest 
frequency of missing data. 
Isolates that had an identical allelic profile to M7124 or had 1-3 nucleotide differences across all 
non-missing cps genes were considered to share the same capsular gene structure with M7124. 
Isolates with >3 nucleotide differences across all cps genes were further examined to identify 
whether nucleotide differences clustered into one or more genes. Any gene that differed from 
M7124 by >3 nucleotide was defined as an ‘allelic shift’ suggestive of a unique recombination in 
that particular gene in a given isolate compared to M7124. Presence and total number of allelic 
shifts were assessed for each isolate. 
Contiguous genome sequences (contigs) containing cps genes for 65 representative isolates 
selected to capture geo-temporal and allelic diversity of the entire collection, were concatenated 
and aligned. MEGA v5.2 83 and CLC genomics workbench v8.0 (www.clcbio.com) were used to 
generate phylogenetic trees and sequence alignments. Maximum likelihood phylogenetic trees 
  
58 
with 500 bootstrap replicates were constructed under the Hasegawa, Kishino and Yano model of 
evolution with Γ-distribution of substitution rates and invariant sites (HKY+ Γ+I). 
4.4 RESULTS  
The cps locus of M7124 is 27kb with genes organized into regions D-A-C-E-D’-B (Figure 11)  
similar to that described for other meningococcal lineages10. When M7124 cps sequences were 
compared to other cps reference sequences, a number of points marking abrupt changes in 
sequence similarity consistent with distinct recombination events were identified:  
1) M7124 shares very high sequence similarity with group W ST-22 reference strain α-275 over 
an 8.4 kb segment that includes all cps region A genes. Genes involved in this recombination 
event (listed from 5’ to 3’) included galE, galU, ctrG, cssF, csW, cscC, cssB and cssA. (Figure 
11). Only 3 nucleotide differences are evident between M7124 and α-275 over the entire 8.4 kb 
segment (Figure 11). Recombination breakpoints at nucleotide positions 858 and 804 on galE 
and cssA genes respectively were demonstrated by alignment of sequences from representative 
meningococcal isolates (Supplementary Figure 11 and 12).  The sialic acid transferase gene, csw 
acquired within this recombination is responsible for capsular group W phenotype (Figure 11). 
Phylogenetic networks (Figure 12) shows that cssA-C and csw gene sequences on M7124 were 
most closely related W ST-22 reference capsule α-275.  
To assess what proportion of W ST-22 strains shared the same recombinant segment with 
M7124, we compared cssB-C, csw and ctrG gene alleles between M7124 and 55 W ST-22 
strains in the PubMLST database. Eighty percent (44/55) of W ST-22 strains shared a common 
allelic profile that differed from M7124 by two nucleotide substitutions within csw. These data 
demonstrate that the recombinant segment is predominant among W ST-22 strains. 
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2) A 13.7kb region of very high sequence similarity between M7124 and the group Y ST-23 
includes 4.5kb of cps and 9.2kb downstream of the cps cluster (Figure 11). The entire region B 
(ctrE and ctrF) and parts of region D’ (rfbA2 and rfbC2) were part of this recombinant segment 
(Figure 11-12). This recombinant segment extends beyond the cps genes and includes the genes 
gltS, encoding a sodium/glucose transport protein, a pyruvate kinase gene (pykA), sel1 and 
several genes encoding hypothetical proteins. A corresponding recombination breakpoint was 
identified at position 611 of rfbA2 gene (Figure 11-12, Supplementary Figure 18) while a 
downstream breakpoint is located outside the cps cluster at the 5’ end of pykA gene.  
We further compared ctrE and ctrF gene alleles between M7124 and 201 Y ST-23 strains in the 
PubMLST database.  Over 88% (177/201) of all Y ST-23 isolates shared identical ctrE and ctrF 
alleles with M7124 demonstrating that this allelic combination is predominant among Y ST-23 
strains. 
M7124 gene sequences were then compared to whole genome sequence data from 524 W ST-11 
strains isolated from 21 different countries. When compared to M7124, the majority of W ST-11 
strains had cps gene sequences that were either identical to M7124 or differed only by ≤3  point 
mutations; 63.7% (334/524) of isolates had cps allelic profiles that were identical to M7124, 
another 162 isolates (30.9%) differed from M7124 by a total of 1-3 point mutations across all cps 
genes. Thus 94.7% (496/524) of W ST-11 strains shared the same  cps gene structure as M7124, 
which predominated across the entire study period from 1970-2014 (Figure 13 and 14). 
Phylogenetic tree constructed using maximum likelihood shows strains with same cps structure 
as M7124 (Figure 15, red boxes) belonged to a single phylogenetic cluster while strains with >3 
SNPs relative to M7124 (Figure 15, blue dots) were diverse; some belonged to the same cluster 
as M7124 while majority were distinct from M7124.   
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Twenty nine strains (29/524, 5.5%) with non M7124 cps gene structure were further examined. 
All had one or more genes that exhibited allelic shift, defined as >3 nucleotide differences within 
a single (Figure 13, blue boxes). Genes with allelic shift likely differed from M7124 reference 
allele through recombination. Among these 29 isolates, 44.2% (13/29) had allelic shift in a single 
cps gene while the remaining 16 isolates shared 2-7 allelic shifts (Figure 13, blue rectangles). 
Seven strains isolated in South Africa in 2006-2013 each had three allelic shifts and shared a 
common cps allelic combination in keeping with geographically limited clonal spread of strains 
with this particular cps allelic profile (Figure 13). Twenty two remaining strains with one or 
more allelic shifts were diverse without any predominant allelic profile and were isolated 
throughout the study period (Figure 14).  
4.5 DISCUSSION 
In this study, we present detailed characterization of the capsule gene locus, the primary 
meningococcal virulence determinant within the context of globally emergent hypervirulent 
group W ST-11 lineage. To our knowledge, this is the first in-depth study of capsule gene 
sequence variation within a single meningococcal lineage.  
Taken together, these data suggest that W ST-11 likely acquired capsule polymerase (csw) gene 
allele along with other region A genes from a W ST-22 strain and acquired capsule translocation 
gene alleles from Y ST-23 lineage. Also, an overwhelming majority of W ST-11 strains had cps 
gene alleles very closely related to M7124 in keeping with a shared capsule recombination 
structure and a common ancestor. Strains with one or more divergent alleles were a very small 
minority but occurred throughout the study period. These data are consistent with recent whole 
genome sequencing studies showing that all W ST-11 strains belonged to a single lineage that is 
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phylogenetically distinct from group C and B ST-11 lineages.98 Very high degree of sequence 
conservation among W ST-11 capsule genes markedly contrasts the substantial global and 
temporal variability in W ST-11 disease incidence patterns, a lineage associated with both rare 
sporadic disease49,58 and epidemics17 In fact, our previous study identified that the Hajj clone and 
its descendants acquired virulence gene alleles, outside of the cps cluster, through a set of unique 
recombination events affecting factor H binding protein (fHbp), nitric oxide reductase (nor) and 
nitrite reductase (aniA) genes.99  
These data suggest that the Hajj clone and a vast majority of W ST-11 strains acquired an 8.4kb 
recombinant fragment from group W ST-22 lineage. This recombination event includes sialic 
acid transferase gene that mediates formation of (α2→6) sialic acid and glucose heteropolymers 
characteristic of group W capsule.10 These findings are consistent with those of Swartley et al34 
that identified allelic exchange spanning over 9kb of cps genes including the entire region A and 
resulting in a group B to C ST-32 capsular switch among isolates obtained during a group B 
epidemic in Oregon, USA. Wang et al102 also reported a switch from group A ST-7 to C in China 
consisting of a  12kb recombination involving the entire cps region A and flanking genes within 
region D and C. These studies highlight that even though allelic exchange within a single gene 
(sialic acid transferase) may be sufficient to cause capsular switching, large recombination 
segments affecting several genes are not uncommon. 
We also identified additional recombination involving genes associated with capsule 
translocation (ctrE, ctrF) from Y ST-23 donor lineage. This recombination event did not involve 
capsule synthesis genes in region A and therefore had no corresponding change in capsular 
group. However, even without an obvious change in capsular phenotype, such allelic exchanges 
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outside region A could affect meningococcal virulence by altering capsule transport and 
modification. 103 CtrE, for example, is up-regulated during meningococcal invasion of human 
cells 104 and recombination within this gene could potentially enhance virulence through 
enhanced intracellular survival of W ST-11.  Persistence of one particular cps allelic combination 
despite continuous generation of closely related allelic variants is consistent with the ‘genocloud’ 
concept in which a main allelic profile persists despite presence of a few, mostly transient, 
escape variants 64. The dominant allelic type likely represents a set of mutually co-adapted genes 
that may confer a fitness advantage to W ST-11 strains.105 
In summary, we have demonstrated that the W ST-11 lineage arose through recombination from 
ancestral group C ST-11 and group Y ST23 strains. Remarkably, this recombination pattern has 
persisted despite decades of global spread and emergence of the epidemic Hajj clone.   
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4.8 FIGURE LEGENDS 
Figure 11: Capsule gene cluster (cps) for W ST-11 reference strain M7124.  Cps is comprised of 
five regions A-E arranged as shown. Two recombination events are depicted; Blue bars:: an 
8.4kb W ST-22 donor fragment; a 13.7kb Y ST-23 donor fragment;  Blue arrows  indicate 
associated recombination breakpoints within galE, cssA and rfbA2.  
Figure 12: Phylogenetic relationships of M7124, W ST-11 to cps from meningococcal reference 
genomes. MC58,  B ST-32; H4476, B ST-41/44 alpha275, W ST-22;  WUE171 W ST-11; 
FAM18, C ST-11; 8013 C ST-18;  53442 C ST-4821; alpha162 Y ST-23. Dotted red boxes 
depict margins of sequence alignments used to generate corresponding phylogenetic network.  
Figure 13: Graphic depiction of 524 W ST-11 cps allelic profiles. Genes with ≤3 nucleotide 
differences to M7124 allele are represented by red arrows, blue arrows represent genes with >3 
nucleotide differences to M7124 within a single gene; white boxes represent genes with 
incomplete sequence data. Strain ID indicates strain identifier of a representative strain within 
each cps allelic profile. N- number of isolates.  
Figure 14: Distribution of W ST-11 cps sequences over time. Red bars depict strains with ≤3 
nucleotide differences across all cps alleles relative to M7124; blue bars depict strains with >3 
SNPs compared to M7124.  
Figure 15: Maximum likelihood tree depicting phylogenetic relationship between selected W 
ST-11 cps sequences. Tree shows strains with ≤3 nucleotide differences to M7124 (red star and 
red squares) and those with ≥4 nucleotide differences to M7124 (blue dots).  
Figure 16: Sequence alignments galE gene showing recombination breakpoints within M7124. 
Sequence alignment of galE genes showing recombination breakpoint at position 858 relative to 
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W ST-22 strain, alpha275. M7124, W ST-11; WUE171, W ST-11; alpha275, W ST-22; FAM18, 
C ST-11; alpha162, Y ST-23; MC58, B ST-32; H4476, B ST-44; 053442, C ST-4821; 8013, C 
ST-18. 
Figure 17: Sequence alignments cssA gene showing recombination at position 804.  
Figure 18: Sequence alignment of rfbA2 and rfbC2 genes showing recombination breakpoint 
within rfbA2 position 634.  
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Figure 11: Capsule gene cluster (cps) for W ST-11 reference strain M7124. 
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Figure 12: Phylogenetic relationships of W ST-11 and cps sequences from meningococcal 
reference genomes. 
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Figure 13: Graphic depiction of 524 W ST-11 cps allelic profiles. 
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Figure 14: Distribution of W ST-11 cps sequences over time. 
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Figure 15: Phylogenetic relationship between W ST-11 cps sequences. 
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Figure 16: Sequence alignments of galE gene showing recombination breakpoint.  
 
 
 
Figure 17: Sequence alignments of cssA gene showing recombination breakpoint.  
 
 
  
72 
 
Figure 18: Sequence alignment of rfbA2 genes showing recombination breakpoint. 
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5.0 DISCUSSION 
5.1 MAJOR FINDINGS 
This dissertation resulted in key findings that illuminate several factors that lead to the 
emergence of W ST-11 as a hypervirulent meningococcal lineage.  
1. All W ST-11 strains shared extensive ancestral mosaic recombination within their 
capsule genes: This finding together with phylogenetic evidence of W ST-11 
representing clonal expansion within the larger group C ST-11 lineage provides strong 
evidence that the majority of global W ST-11 strains represent clonal expansion of a 
single strain that had undergone capsular switching. On one hand, this capsular switch 
strain has spread and persisted globally for at least half a century, suggesting that the 
specific combination of capsular genes confers fitness to W ST-11 strains. On the other 
hand, a varying degree of virulence among W ST-11 strains suggests that genetic 
variation outside of the capsule genes were associated with differences in W ST-11 
epidemiology.  
2. Current W ST-11 strains represent multifocal emergence, as opposed to simple global 
spread of a single strain that was suggested by the traditional model of ST-11 W 
evolution: Whole genome sequence analysis confirmed that several recent endemic W 
ST-11 strains were phylogenetically distinct from the Hajj clone.  
3.  The Hajj clone underwent genetic change that differentiates it from endemic W ST-11 
strains: We identified distinct recombination in antigen encoding and metabolic genes in 
the Hajj clone and its descendants that may have accounted for increased virulence of the 
Hajj clone (Figure 19). These data support the key role of allelic exchange within core 
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genes in the emergence and persistence and evolution of hypervirulent meningococcal 
lineages.  
 
 
Figure 19: Revised genomic model of W ST-11 evolution based on this dissertation research. 
5.2 SIGNIFICANCE  
5.2.1 Public Health significance and implications for vaccination policy. 
Invasive meningococcal disease is a rapidly progressive disease that can cause death within 24-
48 hours in previously healthy individuals or may lead to serious sequelae among survivors.3 
Additionally, outbreaks of meningococcal disease cause substantial economic cost and societal 
disruption.106 Vaccines remain the primary control strategy against meningococcal disease with 
available meningococcal vaccines targeting either the capsule or outer membrane protein 
antigens.26,107 Laboratory surveillance of circulating meningococcal strains is critical for 
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monitoring trends, informing vaccine policy, timely detection of outbreaks, and understanding 
the emergence of new IMD strains.5 
W ST-11 lineage that is associated with the entire epidemiologic spectrum of IMD: sporadic 
disease, smaller outbreaks, high endemic cases and occasional epidemics. An important 
contribution of this dissertation to public health is the provision of useful genomic markers that 
reliably distinguish epidemic from sporadic W ST-11 strains. FHbp genotyping, when combined 
with standard molecular methods such as MLST and PorA antigen typing could provide 
additional resolution in discriminating W ST-11 strains.21 
Successful rollout in 2010-2014 of a highly effective and inexpensive group A vaccine have led 
to the elimination of group A epidemics in the meningitis belt and ushered a new paradigm for 
the vaccine prevention of IMD in the region.108 Group W followed by capsular groups C and X 
are now the leading cause of IMD in the meningitis belt. Data presented in this work demonstrate 
the need for a group W vaccine disease in the meningitis belt. Introduction of a polyvalent 
conjugate vaccine that covers groups A, C, Y, W and ideally X is warranted across the 
meningitis belt in place of the current A conjugate vaccine. In order for such a vaccine to be 
introduced, significant commitment of multiple stakeholders will be needed. A cost-effective 
polyvalent conjugate vaccine can be potentially used beyond the meningitis belt in South Africa, 
parts of Latin America, and Europe that are facing the emergence of W ST-11 and in China 
where group C ST-4821 strain has caused several outbreaks.28,109 In fact, vaccination of 
teenagers with quadrivalent (A,C,W,Y) vaccine recently occurred in the U.K. because of the an 
increase in W ST-11 disease.110 
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Protein conjugate vaccines are effective against meningococcal disease and confer herd 
immunity through reduction in asymptomatic carriage.111 ST-11 clonal complex contains group 
C, B and Y strains and there are concerns that global use of conjugate vaccines could potentially 
lead to selection of capsular switch variants. This is particularly concerning for group B given 
that there is no vaccine that specifically targets group B capsule. However, use of conjugate 
vaccines in the UK112 and United States13 have not led to increased incidence of capsular switch 
strains. Outer membrane vesicle vaccines licensed for the prevention of group B disease retain 
the potential to prevent against non-B capsular groups. One of the vaccines (Bexsero®) contains 
FHbp variant 1, NadA and Nhba antigens. The Hajj clone contains FHbp variant 1 and both the 
Hajj clone and non-Hajj W ST-11 strains contain NadA and Nhba suggesting that this vaccine 
could be protective against W cc11 IMD.67 A second OMV vaccine formulation (Trumenba®) 
contains both FHbp variants 1 and 2/3 but not NadA and Nhba. While this vaccine would be 
effective against both the Hajj clone and non-Hajj W ST-11 strains, there are concerns that 
vaccination with FHbp alone could lead selection of strains with non-functional FHbp genes 
observed in a minority of group C ST-11 strains in Canada.113 
5.2.2 Implication of WGS on molecular epidemiology of IMD.  
Molecular epidemiology, defined as the use of molecular approaches to study the distribution 
and determinants of infectious diseases, complements classic epidemiology in determining 
disease distribution and determinants.114 Molecular techniques provide a framework115 for 
classification of infectious pathogens based on genetic relationships leading to more reliable 
measures of associations between host or agent factors and disease. Molecular epidemiologic 
approaches have helped resolve two global group A pandemics44,64 and elucidated instances 
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where increased IMD burden was caused by expansion of endemic strains116 or introduction of 
new virulent strains.63    
Whole genome sequencing is well suited for detailed typing of meningococcal isolates by 
reference laboratories.117 Riley118 described four key attributes of molecular strain typing 
methods: simplicity, high throughput, cost and appropriateness. WGS has high throughput, 
providing complete genome sequences for hundreds of isolates while generating data that are 
shared in a way that subsequent studies are able to compare their isolates to a global strain 
collection.117 Also, declining costs are making WGS an even more attractive substitute for 
conventional typing of surveillance isolates. Drawbacks of WGS are the need for technical 
expertise and technological infrastructure that is limited in most low resource settings. 
In the last five years, use of WGS for N. meningitidis has expanded beyond a few reference 
strains to sequencing of hundreds of isolates from surveillance and carriage studies.119 
Application of WGS has revised our understanding of several hypervirulent meningococcal 
lineages. In a WGS study, global ST-32 clonal complex was found to consist of three genetically 
distinct sub-lineages that shared different OMP profiles and geo-temporal characteristics.120  
Notably, this study confirmed that differences in OMP profiles within ST-32 complex observed 
between isolates from North Europe and Latin America correspond to deeper underlying 
phylogenetic differences.120 Likewise, genomic comparison of Y ST-23 strains causing endemic 
disease in Sweden discovered that a number of distinct sub-lineages YI-YIII were in circulation 
in Sweden in 1995-2012.121 Although all three sub-lineages were in circulation over the study 
period, increased Y ST-23 disease in Sweden 2007-2012 was largely due to a new YI subtype 
that may have been introduced into Sweden from the United States.27,121 Interestingly, both the 
historically endemic and emergent YI subtypes shared identical OMP profiles making them 
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indistinguishable by conventional molecular typing.121 Likewise, this work99  and a similar WGS 
study98 demonstrated that despite similarity by OMP genotyping, W ST-11 strains consisted of 
phylogenetically and antigenically distinct sub-lineages. Remarkably, strains from South 
America and the UK were closely related and distinct from the Hajj clone and African epidemic 
strains.18,98,99  In summary, WGS studies are providing powerful insight into the complex genetic 
composition of hyperinvasive meningococcal lineages.    
5.2.3 Perspective on Neisseria population genetics.  
This dissertation provides a good case study of the factors at play in the emergence and 
persistence of hypervirulent meningococcal lineages. Meningococcal clonal complexes are 
hypothesized to possess a number of mutually co-adapted set of alleles that persist in a dynamic 
state of genomic flux over time25,122  and maintain a discrete population structure despite 
extensive recombination.100,115 Minor genetic variants arise from major lineages by 
recombination with most recombinant strains being less fit than the progenitor strain.105 Rarely, a 
genetic variant escapes the fitness constraint and persist alongside or may replace the original 
dominant strain.64   
Persistence of a single W ST-11 capsular allelic type suggest that the capsular switching event 
represented a bottleneck event with selective expansion of a single capsular genotype at the 
expense of other intermediate variants and strains with alternative group W capsular 
recombination events. Although, the presence of a capsule was a necessary requirement for 
meningococcal virulence,2 in the case of W ST-11 the capsule alone was not a sufficient cause of 
virulence given that historical W ST-11 strains rarely caused disease. Therefore, capsule 
acquisition represented one important component in a multi-step process of virulence acquisition.  
  
79 
A second genetic bottleneck was associated with the selection and rapid global dissemination of 
a single clone during the Hajj epidemic. Strains belonging to the Hajj clone were genetically 
homogenous with very limited genetic and antigenic diversity compared to extensive diversity 
among non-Hajj W ST-11 strains from both before and after the Hajj epidemic.45,58,61,98,99 This 
work demonstrated that the Hajj clone had acquired a unique surface antigen gene (fHbp) and a 
number of genetic elements such as aniA and nor genes associated with nasopharyngeal survival 
of meningococci. These genetic factors may have conferred a fitness advantage that led to rapid 
clonal expansion of the Hajj clone at the expense of other W ST-11 strains. Subsequently, the 
Hajj clone was introduced and co-existed within a background of genetically heterogeneous 
endogenous W ST-11 strains in the meningitis belt and South Africa. Instead of replacing 
endogenous W ST-11 strains in these countries, the Hajj clone co-circulated and co-existed with 
these endogenous W ST-11 strains. It is not known whether the Hajj clone predominantly 
affected a different demographic or existed in different provinces within these countries 
compared endogenous W ST-11 strains which could explain co-circulation without direct 
competition among W ST-11 strains.123    
Factors beyond the pathogen genetic composition play a substantial role in determining the 
epidemiological characteristics of meningococcal strains. Population susceptibility to virulent 
meningococcal strains is dependent on immunity acquired through natural exposure to 
circulating meningococci or through vaccination, crowding, weather conditions, age 
composition, and smoking.2,8,124-126 Spread of the Hajj clone provides an interesting example of 
an identical meningococcal strain that when introduced into different human populations led to 
epidemics in the meningitis belt,17,66,73 hyperendemic cases in South Africa,52 and small localized 
outbreaks in the UK14,43 and France.61 Likewise, introduction of the Hajj clone in the UK in 
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2000-2001 caused much fewer IMD cases than the introduction of the ‘South American’ W ST-
11 strain in 2010-2014 which required targeted vaccination of teenagers.110 It is of concern 
whether the continued spread of the South American W ST-11 strain could lead to meningitis 
belt epidemics.  Therefore, environmental and behavioral factors play a central role in the 
emergence of virulent meningococci and assessment of virulence must take cognizance of the 
particular epidemiologic context.  
5.3 LIMITATIONS 
A limitation of this study is that invasive strains represent a highly biased sub-population of 
isolates that may not reflect true meningococcal population genetic diversity.126,127 Also, IMD 
surveillance in some global regions is weak and only a limited number of historical isolates had 
WGS. However, our results are supported by extensive WGS data for hundreds of IMD 
surveillance isolates from UK and South Africa. Another limitation of global comparison of IMD 
isolates is the difficulty in dis-entangling the contribution of differing socioeconomic, 
behavioral, and climatic factors to observed differences in disease incidence.  
5.4 FUTURE DIRECTIONS 
This dissertation explores the molecular and genomic epidemiology of meningococcal disease 
using emergent W ST-11 strain as a case example. Bioinformatics methods applied in this work 
can be applied to the study of other emerging meningococcal lineages such as group C ST-4821 
causing epidemics in China,28 group Y ST-23 strains associated with increasing endemic disease 
in the United States35 and across Europe22 and emerging group C ST-10217 in parts of the 
meningitis belt.15 Neisseria PubMLST database has facilitated several comparative genomic 
studies including that reported in this dissertation. However, the potential of this database for 
more extensive genomic comparison between meningococci and among other Neisseria species 
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is yet to be fully realized. Strengthened IMD surveillance on a global scale and wider application 
of WGS is needed to monitor the continuing evolution of W ST-11. There is also a need for an 
affordable multivalent protein conjugate vaccine that prevents groups W and C meningococcal 
disease in the meningitis belt.     
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APPENDIX A: SUPPLEMENTARY MATERIAL FOR PAPER 2 
 
Supplementary Methods 
DNA extraction: Isolates for DNA extraction were subcultured from a single colony and grown 
overnight at 37°C with 5% CO2 on chocolate agar plates. DNA for Sanger sequencing was 
extracted by a NucliSENs easyMAG system (bioMérieux, Durham, NC) and by boiling a heavy 
suspension of organisms in 0.5mL of PBS. DNA for Illumina and Ion Torrent sequencing was 
extracted by using the DNeasy blood and tissue kit (QIAGEN, Valencia, CA). DNA for PacBio 
sequencing was extracted using the Easy-DNA gDNA Purification Kit (Invitrogen, Grand Island, 
NY). 
Multilocus sequene typing (MLST) and outer membrane protein (OMP) gene sequencing:  For 
all 26 sequenced genomes PCR based MLST and OMP gene sequence typing of PorA VR1 and 
VR2, and FetA VR were performed as described.128 Sequence alleles and sequence types were 
determined by querying the PubMLST database. MLST and OMP results were compared to 
those obtained by querying assembled contigs on PubMLST database. MLST and OMP typing 
for public genomes were obtained by querying genome sequences against the PubMLST 
database.  
16S rRNA gene sequencing: PCR amplification and sequence analysis of the 16S rRNA genes 
were performed using modifications of published methods.42,87 Primers 8F and 1492R were used 
for amplification. All reactions were carried out in 50-μl volumes containing 1 μl of purified 
genomic DNA (~20 ng), 1× AmpliTaq Gold PCR buffer (15 mM Tris-HCl, pH 8.0, 50 mM 
KCl), 2.5 mM MgCl2, 0.2 mM each deoxynucleoside triphosphate, 0.2 μM of each primer, and 
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1.5 units AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster City, CA). Cycling 
conditions were an initial denaturation step at 95°C for 5 min followed by 35 cycles of 95°C for 
1 min, 50°C for 1 min and 72°C for 1.5 min, followed by a final extension step for 7 min at 
72°C. PCR products were purified with Exo-Sap It (Affymetrix, Santa Clara, CA) and sequenced 
with BigDye Terminator v3.1 Cycle Sequencing Kit according to manufacturer’s instructions 
using previously described primers 8F, 1492R, 357, 530, 790, 981, 1968F and 1083F.42,87 
Sequence contigs were analyzed and compared to 16S type 13 and 31 by using DNAstar 
Lasergene SeqMan Pro software (v.11.2; DNAstar, Madison, WI). 
SNP-based whole genome phylogenetic tree (Figure 24) was generated by aligning sequence 
reads of 153 N. meningitidis genome sequences against M7124 genome. Aligned reads were 
sorted and filtered as descrided in Methods. 140,903 SNP positions were concatenated and a 
maximum likelihood tree generated under General Time Reversible model, gamma distribution 
of rate variation with invariant sites (GTR+Γ+I). 
Quality assessment: Several steps were taken during isolate selection, genome assembly, and 
data analyses to assure data quality and consistency of results. For all 26 newly sequenced 
genomes at least three iterations of genome assemblies were run and the the assembly with the 
best assembly quality metrics (low assembly gaps, high average median contig size and larger 
total genome size) is selected. Assembly quality was further assessed by comparing newly 
sequenced genomes to both group C ST-11 reference strain, FAM18 and M7124 using multiple 
genome alignments on Mauve v2.3. In addition, read mapping and SNP analyses were used to 
compare data obtained from different platforms for re-sequenced isolates. No major 
discrepancies in the form of insertion-deletion, translocation or inconsistent genome sizes were 
identified.  
  
84 
Three isolates that originally had IonTorrent data were re-sequenced using PacBio to assess 
whether the relatively large number of assembly gaps obtained from IonTorrent affected 
phylogenetic clustering of these isolates. Re-sequencing did not change the phylogenetic 
relationships between strains in our study (data not shown). To ascertain that only good quality 
genome assemblies were included from PubMLST database, genomes that had incomplete data 
at one of six antigen gene alleles were excluded from the study. 
For whole genome phylogenetic analyses, isolates were selected to capture geographic and 
antigen gene allelic diversity of the entire set of 270 isolates. Among isolates sharing similar 
allelic and geographic profiles, one with the best genome assembly parameters was selected as a 
representative strain. ‘Iterative refinement’ option was selected to improve genome alignment 
accuracy while poorly aligned genomic regions were excluded by including only core genome 
segments that were conserved in all aligned genomes and were at least 500bp in size. The 
resultant core genome Maximum Likelihood phylogenetic tree remained unchanged after 
increasing the minimum alignment block size to 2000bp and/or removing very small alignment 
gaps not addressed by Mauve using GBlocks (results not shown). SNP analysis was limited to 20 
genomes that had short read sequencing data (Illumina, IonTorrent, 454). PacBio reads were not 
used for SNP calling because the tools we used (bwa, samtools) were not designed to handle 
long read sequence data.  
Finally, we compared results of separate phylogenetic trees constructed using ClonalFrame, 
SptitsTree and Maximum Likelihood to allelic profiles of antigen encoding genes. Concordance 
between these data and available epidemiologic information for these isolates provided further 
reassurance of the validity of these results.   
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Figure 20: Phylogenetic tree of Hajj cluster recombinant region 1. 
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Figure 21: Phylogenetic tree of Hajj cluster recombinant region 2. 
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Figure 22: Phylogenetic tree of Hajj cluster recombinant region 3. 
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Figure 23: Phylogenetic tree of Hajj cluster recombinant region 4.  
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Figure 24: Phylogenetic tree of serogroup W, C and B ST-11 strains in relation to other 
hyperinvasive meningococcal lineages. 
 
 
  
90 
Table 2. Characteristics of 26 meningococcal genomes sequenced in this study. 
Strain 
ID 
Sequencing 
technology 
GC 
content Coverage 
Assembly 
method 
Number 
of 
contigs 
GenBank 
Accession No. 
Genome 
size 
Largest 
contig 
size 
Median 
contig 
size 
Smallest 
contig 
size 
N501 N902 
M7124 PacBio3 51.7 130.9 HGAP v2.0 1 CP009419 2179483 - - - - - 
NM3686 PacBio 51.7 173.0 HGAP v2.0 1 CP009418 2195266 - - - - - 
NM3687 PacBio 51.6 219.8 HGAP v2.0 10 JRET00000000 2223230 1610344 47059 4073 1609697 103326 
NM3681 PacBio 51.7 62.1 HGAP v2.0 2 JREU00000000 2217098 1380815 415099 6085 1380815 12054 
NM3682 PacBio 51.7 60.0 HGAP v2.0 1 CP009420 2185359 - - - - - 
M10208 PacBio 51.7 55.0 HGAP v2.0 1 CP009422 2183230 - - - - - 
M20599 PacBio 51.8 60.0 HGAP v2.0 13 JRFG00000000    2258407 1053953 19069 4563 516162 150267 
M1412 Ion Torrent4 51.7 62.6 Mira v3.9 320 JRFH00000000 2110370 39255 4109 504 12232 3559 
M12611 Ion Torrent 51.8 70.8 Mira v3.9 698 JRFI00000000 1914608 13374 2130 10001 3305 1405 
M7089 Illumina+4545 51.7 32.0 Celera v7.0 31 ANRN00000000 2174132 280052 51414 1714 133850 49971 
2001213 Illumina6 51.9 54.7 Celera v7.0 125 APUD00000000 2145367 107785 10070 516 29037 8528 
2004264 Illumina 52.0 57.6 Celera v7.0 132 APUE00000000 2223810 87880 11580 179 27158 8339 
2005079 Illumina 52.0 61.6 Celera v7.0 132 APUG00000000 2121623 78339 10799 136 27213 8691 
2005040 Illumina 52.0 62.4 Celera v7.0 133 APUI00000000 2156155 169873 10487 146 27155 9111 
2001072 Illumina 51.9 75.5 Celera v7.0 131 APTY00000000 2157792 124299 10473 120 26510 8615 
2001073 Illumina 51.9 79.4 Celera v7.0 137 APTZ00000000 2143674 86269 10192 118 28492 8200 
2002004 Illumina 51.9 55.9 Celera v7.0 137 APUJ00000000 2256966 68617 12347 133 26724 8625 
2000081 Illumina 51.9 60.4 Celera v7.0 140 APUA00000000 2180008 63594 10344 101 26618 8225 
NM174 Illumina+454 51.7 43.1 Celera v7.0 19 ANRP00000000 2180278 771479 80215 1914 161674 67157 
2000175 Illumina 51.9 51.4 Celera v7.0 134 APUF00000000 2233577 93253 11468 224 25838 8910 
2001068 Illumina 51.9 70.2 Celera v7.0 136 APUH00000000 2214688 94883 11879 648 24221 8778 
NM3680 Ion Torrent 51.8 63.2 Mira v3.9 250 JSAR00000000 2101022 65014 5616 507 15072 4516 
NM3684 Ion Torrent 51.7 64.1 Mira v3.9 261 JSAS00000000 2132590 55229 5131 497 16290 4425 
NM3685 Ion Torrent 51.7 47.3 Mira v3.9 280 JSAT00000000 2122125 49178 4782 497 13937 3925 
NM3688 Ion Torrent 51.6 63.7 Mira v3.9 249 JSAU00000000 2165310 59342 5196 501 17223 4867 
NM3147 Illumina 52.0 81.06 Celera v7.0 136 APTX00000000 2256933 94650 10744 101 29024 8163 
 
1N50: 50% of the entire genome is contained in contigs equal to or larger than this value.   
2N90: 90% of the entire genome is contained in contigs equal to or larger than this value; HGAP: Hierarchical genome assembly process. 
3Pacific BioSciences RS II sequencing (www.pacificbiosciences.com/) 
4Life Technologies Ion Torrent PGM sequencing (www.lifetechnologies.com) 
5Roche 454 sequencing (www.454.com) 
6Paired end Illumina MiSEQ (www.illumina.com/)  
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Table 3. List of six Cluster 1 isolates that shared only three out of four recombinant regions with 
M7124. 
Isolate ID Country Year Recombinant 
region* 
Percent 
identity 
Alignment 
length 
Mismatches Gaps 
21583 South Africa 2011 1 82.98 1163 178 5 
29326 South Africa 2005 1 82.98 1163 178 5 
29336 South Africa 2010 1 82.98 1163 178 5 
29402 South Africa 2013 1 82.98 1163 178 5 
29387 South Africa 2013 3 99.1 4016 34 1 
29393 South Africa 2008 4 98.23 2031 36 0 
*Recombinant region numbers correspond to those on Table 1   
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